| Year |
Citation |
Score |
| 2022 |
Yang Y, Sheng J, Hu S, Cui Y, Xiao J, Yu W, Peng J, Han W, He Q, Fan Y, Niu Y, Lin J, Tian Y, Chang C, Yeh S, et al. Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis. Cell Death & Disease. 13: 533. PMID 35672281 DOI: 10.1038/s41419-022-04979-3 |
0.304 |
|
| 2021 |
Zhang M, Sun Y, Huang CP, Luo J, Zhang L, Meng J, Liang C, Chang C. Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression. Cell Death & Disease. 12: 855. PMID 34545067 DOI: 10.1038/s41419-021-03966-4 |
0.349 |
|
| 2021 |
Deng G, Wang R, Sun Y, Huang CP, Yeh S, You B, Feng C, Li G, Ma S, Chang C. Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals. Cell Death and Differentiation. PMID 34127806 DOI: 10.1038/s41418-021-00743-w |
0.312 |
|
| 2021 |
Lee SO, Ma Z, Yeh CR, Luo J, Lin TH, Lai KP, Yamashita S, Liang L, Tian J, Li L, Jiang Q, Huang CK, Niu Y, Yeh S, Chang C. Corrigendum to: 'New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells'. Journal of Molecular Cell Biology. PMID 33537701 DOI: 10.1093/jmcb/mjaa077 |
0.812 |
|
| 2021 |
You B, Sun Y, Luo J, Wang K, Liu Q, Fang R, Liu B, Chou F, Wang R, Meng J, Huang CP, Yeh S, Chang C, Xu W. Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR. Oncogene. PMID 33510354 DOI: 10.1038/s41388-020-01616-1 |
0.34 |
|
| 2021 |
Tian H, Chou FJ, Tian J, Zhang Y, You B, Huang CP, Yeh S, Niu Y, Chang C. ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling. Journal of Experimental & Clinical Cancer Research : Cr. 40: 3. PMID 33390173 DOI: 10.1186/s13046-020-01760-2 |
0.369 |
|
| 2020 |
Hu YC, Yeh S, Yeh SD, Sampson ER, Huang J, Li P, Hsu CL, Ting HJ, Lin HK, Wang L, Kim E, Ni J, Chang C. Correction: Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. The Journal of Biological Chemistry. 295: 17382. PMID 33453984 DOI: 10.1074/jbc.AAC120.016763 |
0.824 |
|
| 2020 |
Hu YC, Yeh S, Yeh SD, Sampson ER, Huang J, Li P, Hsu CL, Ting HJ, Lin HK, Wang L, Kim E, Ni J, Chang C. Correction: Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. The Journal of Biological Chemistry. 295: 17382. PMID 33310747 DOI: 10.1074/jbc.AAC120.016763 |
0.824 |
|
| 2020 |
Tian J, Ok Lee S, Liang L, Luo J, Huang CK, Li L, Niu Y, Chang C. Correction: Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis. The Journal of Biological Chemistry. 295: 16469. PMID 33246943 DOI: 10.1074/jbc.AAC120.016615 |
0.689 |
|
| 2020 |
Lin TH, Lee SO, Niu Y, Xu D, Liang L, Li L, Yeh SD, Fujimoto N, Yeh S, Chang C. Correction: Differential androgen deprivation therapies with anti-androgens Casodex/bicalutamide or MDV3100/enzalutamide anti-androgen receptor ASC-J9 lead to promotion suppression of prostate cancer metastasis. The Journal of Biological Chemistry. 295: 15796. PMID 33188084 DOI: 10.1074/jbc.AAC120.016502 |
0.685 |
|
| 2020 |
Lai KP, Yamashita S, Vitkus S, Shyr CR, Yeh S, Chang C. Corrigendum to: "Suppressed Prostate Epithelial Development with Impaired Branching Morphogenesis in Mice Lacking Stromal Fibromuscular Androgen Receptor". Endocrinology. 161. PMID 32966551 DOI: 10.1210/endocr/bqaa148 |
0.832 |
|
| 2020 |
Huang Q, Sun Y, Zhai W, Ma X, Shen D, Du S, You B, Niu Y, Huang CP, Zhang X, Chang C. Androgen receptor modulates metastatic routes of VHL wild-type clear cell renal cell carcinoma in an oxygen-dependent manner. Oncogene. PMID 32943729 DOI: 10.1038/S41388-020-01455-0 |
0.381 |
|
| 2020 |
Altuwaijri S, Chuang KH, Lai KP, Lai JJ, Lin HY, Young FM, Bottaro A, Tsai MY, Zeng WP, Chang HC, Yeh S, Chang C. Corrigendum to: "Susceptibility to Autoimmunity and B Cell Resistance to Apoptosis in Mice Lacking Androgen Receptor in B Cells". Endocrinology. 161. PMID 32822479 DOI: 10.1210/Endocr/Bqaa118 |
0.798 |
|
| 2020 |
Chen D, Chou FJ, Chen Y, Tian H, Wang Y, You B, Niu Y, Huang ZP, Yeh S, Xing N, Chang C. Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity. Cancer Letters. PMID 32768524 DOI: 10.1016/J.Canlet.2020.07.040 |
0.381 |
|
| 2020 |
Altuwaijri S, Lee DK, Chuang KH, Ting HJ, Yang Z, Xu Q, Tsai MY, Yeh S, Hanchett LA, Chang HC, Chang C. Correction to: Androgen receptor regulates expression of skeletal muscle-specific proteins and muscle cell types. Endocrine. PMID 32617754 DOI: 10.1007/S12020-020-02350-0 |
0.787 |
|
| 2020 |
Liu G, Ouyang X, Sun Y, Xiao Y, You B, Gao Y, Yeh S, Li Y, Chang C. The miR-92a-2-5p in exosomes from macrophages increases liver cancer cells invasion via altering the AR/PHLPP/p-AKT/β-catenin signaling. Cell Death and Differentiation. PMID 32587378 DOI: 10.1038/S41418-020-0575-3 |
0.332 |
|
| 2020 |
Song W, Li L, He D, Xie H, Chen J, Yeh CR, Sien-Shih Chang L, Yeh S, Chang C. Corrigendum to "Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR) → c-Myc signals" [Cancer Lett. 2015 Nov 1 368(1) 71-78]. Cancer Letters. PMID 32487367 DOI: 10.1016/J.Canlet.2020.05.017 |
0.386 |
|
| 2020 |
Wang K, Luo J, Yeh S, You B, Meng J, Chang P, Niu Y, Li G, Lu C, Zhu Y, Antonarakis ES, Luo J, Huang CP, Xu W, Chang C. The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer. Nature Communications. 11: 2689. PMID 32483206 DOI: 10.1038/S41467-020-15396-5 |
0.392 |
|
| 2020 |
Gu J, Zhang Y, Han Z, Gao L, Cui J, Sun Y, Niu Y, You B, Huang CP, Chang C, Wang X, Yeh S. Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC. Cell Death & Disease. 11: 367. PMID 32409702 DOI: 10.1038/S41419-020-2486-0 |
0.394 |
|
| 2020 |
He M, Yu W, Chang C, Miyamoto H, Liu X, Jiang K, Yeh S. Estrogen receptor α increases lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways. Molecular Oncology. PMID 32356397 DOI: 10.1002/1878-0261.12701 |
0.373 |
|
| 2020 |
Xu H, Sun Y, Huang CP, You B, Ye D, Chang C. Preclinical Study Using ABT263 to Increase Enzalutamide Sensitivity to Suppress Prostate Cancer Progression Via Targeting BCL2/ROS/USP26 Axis Through Altering ARv7 Protein Degradation. Cancers. 12. PMID 32235588 DOI: 10.3390/Cancers12040831 |
0.401 |
|
| 2020 |
Zhao J, Sun Y, Lin H, Chou F, Xiao Y, Jin R, Cai X, Chang C. Olaparib and enzalutamide synergistically suppress HCC progression via the AR-mediated miR-146a-5p/BRCA1 signaling. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 32134529 DOI: 10.1096/Fj.201903045Rr |
0.335 |
|
| 2020 |
Chen J, Sun Y, Ou Z, Yeh S, Huang CP, You B, Tsai YC, Sheu TJ, Zu X, Chang C. Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion. Embo Reports. e48467. PMID 32052578 DOI: 10.15252/Embr.201948467 |
0.393 |
|
| 2020 |
Luo* J, Meng J, Messing EM, Joseph JV, Yeh S, Chang C. MP79-14 LNCRNA-P21 ALTERS THE ANTIANDROGEN ENZALUTAMIDE-INDUCED PROSTATE CANCER NEUROENDOCRINE DIFFERENTIATION VIA MODULATING THE EZH2/STAT3 SIGNALING The Journal of Urology. 203: e1221. DOI: 10.1097/Ju.0000000000000971.014 |
0.383 |
|
| 2020 |
Cui Y, Sun Y, Yang Y, Hu S, Niu Y, Zhang X, Yeh S, Chang C, Jin J. Pd59-03 Hypoxia Induce Neuroendocrine Differentiation Of Prostate Cancer Via Androgen Receptor Related Signals The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000969.03 |
0.395 |
|
| 2020 |
Tao L, Meng J, Messing EM, Joseph JV, Chang C, Qiu J, Yeh S. MP17-19 RECRUITED T CELLS PROMOTE THE BLADDER CANCER METASTASIS VIA UP-REGULATION OF THE ESTROGEN RECEPTOR β/IL-1/C-MET SIGNALS The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000842.020 |
0.337 |
|
| 2019 |
Xu H, Sun Y, You B, Huang CP, Ye D, Chang C. Androgen receptor reverses the oncometabolite R-2-hydroxyglutarate-induced prostate cancer cell invasion via suppressing the circRNA-51217/miRNA-646/TGFβ1/p-Smad2/3 signaling. Cancer Letters. PMID 31846689 DOI: 10.1016/J.Canlet.2019.12.014 |
0.394 |
|
| 2019 |
Hu L, Sun Y, Luo J, He X, Ye M, Li G, Zhang Y, Bai J, Zhang D, Chang C. Targeting TR4 nuclear receptor with antagonist bexarotene increases docetaxel sensitivity to better suppress the metastatic castration-resistant prostate cancer progression. Oncogene. PMID 31748715 DOI: 10.1038/S41388-019-1070-5 |
0.421 |
|
| 2019 |
Chen J, Chou F, Yeh S, Ou Z, Shyr C, Huang C, Xiang Z, Sun Y, Messing E, Zu X, Chang C. Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Gαi protein/MAPK/MMP9 intracellular signaling. Oncogene. PMID 31506605 DOI: 10.1038/S41388-019-0964-6 |
0.722 |
|
| 2019 |
Shi H, Sun Y, He M, Yang X, Hamada M, Fukunaga T, Zhang X, Chang C. Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression. Oncogene. PMID 31501521 DOI: 10.1038/S41388-019-0962-8 |
0.358 |
|
| 2019 |
Hung YY, Huang YL, Chang C, Kang HY. Deficiency in Androgen Receptor Aggravates the Depressive-Like Behaviors in Chronic Mild Stress Model of Depression. Cells. 8. PMID 31480771 DOI: 10.3390/Cells8091021 |
0.324 |
|
| 2019 |
Huang CP, Chen J, Chen CC, Liu G, Zhang Y, Messing E, Yeh S, Chang C. ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-κB survival signals. Journal of Experimental & Clinical Cancer Research : Cr. 38: 275. PMID 31234917 DOI: 10.1186/S13046-019-1258-0 |
0.314 |
|
| 2019 |
Luo J, Wang K, Yeh S, Sun Y, Liang L, Xiao Y, Xu W, Niu Y, Cheng L, Maity SN, Jiang R, Chang C. LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling. Nature Communications. 10: 2571. PMID 31189930 DOI: 10.1038/S41467-019-09784-9 |
0.417 |
|
| 2019 |
Zhu S, Tian H, Niu X, Wang J, Li X, Jiang N, Wen S, Chen X, Ren S, Xu C, Chang C, Flores-Morales A, Shang Z, Sun Y, Niu Y. Correction: Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer. Oncogene. PMID 31048775 DOI: 10.1038/S41388-019-0827-1 |
0.405 |
|
| 2019 |
Wang K, Sun Y, Guo C, Liu T, Fei X, Chang C. Androgen receptor regulates ASS1P3/miR-34a-5p/ASS1 signaling to promote renal cell carcinoma cell growth. Cell Death & Disease. 10: 339. PMID 31000693 DOI: 10.1038/S41419-019-1330-X |
0.361 |
|
| 2019 |
Zhu W, Zhao Z, Chou F, Zuo L, Liu T, Yeh S, Bushinsky D, Zeng G, Chang C. Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals. Cell Death & Disease. 10: 275. PMID 30894518 DOI: 10.1097/Ju.0000000000000830.05 |
0.301 |
|
| 2019 |
Meng L, Li Y, Ren J, Shi T, Men J, Chang C. Early Stage Biomarkers Screening of Prostate Cancer Based on Weighted Gene Coexpression Network Analysis. Dna and Cell Biology. PMID 30835547 DOI: 10.1089/Dna.2018.4406 |
0.328 |
|
| 2019 |
Shang Z, Yu J, Sun L, Tian J, Zhu S, Zhang B, Dong Q, Jiang N, Flores-Morales A, Chang C, Niu Y. LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex. Nucleic Acids Research. PMID 30773595 DOI: 10.1093/Nar/Gkz108 |
0.381 |
|
| 2019 |
Zhu S, Tian H, Niu X, Wang J, Li X, Jiang N, Wen S, Chen X, Ren S, Xu C, Chang C, Flores-Morelas A, Shang Z, Sun Y, Niu Y. Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer. Oncogene. PMID 30770901 DOI: 10.1038/S41388-019-0750-5 |
0.481 |
|
| 2019 |
Chou FJ, Chen Y, Chen D, Niu Y, Li G, Keng P, Yeh S, Chang C. Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression. Ebiomedicine. PMID 30692044 DOI: 10.1016/J.Ebiom.2018.12.050 |
0.457 |
|
| 2019 |
Wu G, Sun Y, Xiang Z, Wang K, Liu B, Xiao G, Niu Y, Wu D, Chang C. Preclinical study using circular RNA 17 and micro RNA 181c-5p to suppress the enzalutamide-resistant prostate cancer progression. Cell Death & Disease. 10: 37. PMID 30674872 DOI: 10.1038/S41419-018-1048-1 |
0.385 |
|
| 2019 |
Wang R, Chang C, Yeh S. Mp68-17 Enzalutamide-Induced Antiandrogen-Resistance Via A Unique Trans-Splicing Mechanism To Induce A Novel Androgen Receptor Mutant Arv33 The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557032.17578.89 |
0.355 |
|
| 2018 |
Xiao Y, Sun Y, Liu G, Zhao J, Gao Y, Yeh S, Gong L, Chang C. Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in the altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype. Cancer Letters. PMID 30448543 DOI: 10.1016/J.Canlet.2018.11.004 |
0.312 |
|
| 2018 |
Zhang M, Sun Y, Meng J, Zhang L, Liang C, Chang C. Targeting AR-Beclin 1 Complex-Modulated Growth Factor Signaling Increases the Antiandrogen-Enzalutamide Sensitivity to Better Suppress the Castration-Resistant Prostate Cancer Growth. Cancer Letters. PMID 30423407 DOI: 10.1016/J.Canlet.2018.11.008 |
0.41 |
|
| 2018 |
Luo J, Tian J, Chou F, Lin C, Xing EZ, Zuo L, Niu Y, Yeh S, Chang C. Targeting the androgen receptor (AR) with AR degradation enhancer ASC-J9 led to increase docetaxel sensitivity via suppressing the p21 expression. Cancer Letters. PMID 30248372 DOI: 10.1016/J.Canlet.2018.09.025 |
0.449 |
|
| 2018 |
Niu Y, Guo C, Wen S, Tian J, Luo J, Wang K, Tian H, Yeh S, Chang C. ADT with antiandrogens in prostate cancer induces adverse effect of increasing resistance, neuroendocrine differentiation and tumor metastasis. Cancer Letters. PMID 30227222 DOI: 10.1016/J.Canlet.2018.09.020 |
0.451 |
|
| 2018 |
Song W, He D, Chen Y, Yeh CR, Hsu I, Huang Q, Zhang X, Chang LS, Zuo L, Chen J, Doersch KM, Chang C, Yeh S. Targeting newly identified ERβ/TGFβ-1/SMAD3 signals with the FDA-approved antiestrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma. Molecular Oncology. PMID 30171816 DOI: 10.1002/1878-0261.12377 |
0.355 |
|
| 2018 |
Bai J, Yeh S, Qiu X, Hu L, Zeng J, Cai Y, Zuo L, Li G, Yang G, Chang C. TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals. Oncogene. PMID 29973687 DOI: 10.1038/S41388-018-0269-1 |
0.336 |
|
| 2018 |
Ding J, Yeh CR, Sun Y, Lin C, Chou J, Ou Z, Chang C, Qi J, Yeh S. Estrogen receptor β promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network. Oncogene. PMID 29789714 DOI: 10.1038/S41388-018-0175-6 |
0.313 |
|
| 2018 |
Tao L, Qiu J, Slavin S, Ou Z, Liu Z, Ge J, Guancial EA, Messing EM, Chang C, Yeh S. Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor β/IL-1/c-MET signals. Cancer Letters. PMID 29684419 DOI: 10.1016/J.Canlet.2018.03.045 |
0.355 |
|
| 2018 |
Han Z, Zhang Y, Sun Y, Chen J, Chang C, Wang X, Yeh S. ERβ-mediated alteration of circATP2B1 and miR-204-3p signaling promotes invasion of clear cell renal cell carcinoma. Cancer Research. PMID 29490945 DOI: 10.1158/0008-5472.Can-17-1575 |
0.317 |
|
| 2018 |
Lin W, Luo J, Sun Y, Lin C, Li G, Niu Y, Chang C. ASC-J9® suppresses prostate cancer cell invasion via altering the sumoylation-phosphorylation of STAT3. Cancer Letters. PMID 29425687 DOI: 10.1016/J.Canlet.2018.02.007 |
0.475 |
|
| 2018 |
Wang M, Sun Y, Xu J, Lu J, Wang K, Yang DR, Yang G, Li G, Chang C. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling. International Journal of Cancer. PMID 29396852 DOI: 10.1002/Ijc.31289 |
0.326 |
|
| 2018 |
Bai J, Chen J, Qiu X, Yeh S, Hu L, Zeng J, Cai Y, Li G, Messing EM, Yang G, Chang C. MP88-08 TR4 NUCLEAR RECEPTOR PROMOTES CLEAR CELL RENAL CELL CARCINOMA (CCRCC) VASCULOGENIC MIMICRY (VM) FORMATION AND METASTASIS VIA ALTERING THE MIR490-3P/VIMENTIN SIGNALS Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.2928 |
0.306 |
|
| 2018 |
Yang Y, Shen J, Jin S, Xiang P, Fan Y, Lv T, He Q, Yu W, Hu S, Chang C, Yeh S, Jin J. MP45-02 INCREASED STROMAL COMPONENTS AND PROSTATIC FIBROSIS VIA ALTERING THE CYP19/ESTROGEN/GPER SIGNALING IN THE EARLY PROGRESSION OF BPH TISSUES OF MEN ≤ 50 YEARS OLD Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1441 |
0.368 |
|
| 2017 |
Jiang N, Ke B, Hjort-Jensen K, Iglesias-Gato D, Wang Z, Chang P, Zhao Y, Niu X, Wu T, Peng B, Jiang M, Li X, Shang Z, Wang Q, Chang C, et al. YAP1 regulates prostate cancer stem cell-like characteristics to promote castration resistant growth. Oncotarget. 8: 115054-115067. PMID 29383141 DOI: 10.18632/Oncotarget.23014 |
0.461 |
|
| 2017 |
Cheng MA, Chou FJ, Wang K, Yang R, Ding J, Zhang Q, Li G, Yeh S, Xu D, Chang C. Androgen receptor (AR) degradation enhancer ASC-J9® in an FDA-approved formulated solution suppresses castration resistant prostate cancer cell growth. Cancer Letters. PMID 29203251 DOI: 10.1016/J.Canlet.2017.11.038 |
0.47 |
|
| 2017 |
Deng SL, Wang ZP, Jin C, Kang XL, Batool A, Zhang Y, Li XY, Wang XX, Chen SR, Chang CS, Cheng CY, Lian ZX, Liu YX. Melatonin promotes sheep Leydig cell testosterone secretion in a co-culture with Sertoli cells. Theriogenology. 106: 170-177. PMID 29073541 DOI: 10.1016/J.Theriogenology.2017.10.025 |
0.387 |
|
| 2017 |
Huang Q, Sun Y, Ma X, Gao Y, Li X, Niu Y, Zhang X, Chang C. Androgen receptor increases hematogenous metastasis yet decreases lymphatic metastasis of renal cell carcinoma. Nature Communications. 8: 918. PMID 29030639 DOI: 10.1038/S41467-017-00701-6 |
0.367 |
|
| 2017 |
Chen J, Li L, Yang Z, Luo J, Yeh S, Chang C. Androgen-deprivation therapy with enzalutamide enhances prostate cancer metastasis via decreasing the EPHB6 suppressor expression. Cancer Letters. PMID 28826721 DOI: 10.1016/J.Canlet.2017.08.014 |
0.465 |
|
| 2017 |
Zhai W, Sun Y, Guo C, Hu G, Wang M, Zheng J, Lin W, Huang Q, Li G, Zheng J, Chang C. LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals. Cell Death and Differentiation. PMID 28644440 DOI: 10.1038/Cdd.2017.74 |
0.388 |
|
| 2017 |
Wang R, Sun Y, Li L, Niu Y, Lin W, Lin C, Antonarakis ES, Luo J, Yeh S, Chang C. Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9(®) to Suppress Enzalutamide-resistant Prostate Cancer Progression. European Urology. PMID 28528814 DOI: 10.1016/J.Eururo.2017.04.005 |
0.439 |
|
| 2017 |
Lin SJ, Yang DR, Yang G, Lin CY, Chang HC, Li G, Chang C. TR2 and TR4 Orphan Nuclear Receptors: An Overview. Current Topics in Developmental Biology. 125: 357-373. PMID 28527578 DOI: 10.1016/Bs.Ctdb.2017.02.002 |
0.741 |
|
| 2017 |
Lin SJ, Chou FJ, Li L, Lin CY, Yeh S, Chang C. Natural killer cells suppress enzalutamide resistance and cell invasion in the castration resistant prostate cancer via targeting the androgen receptor splicing variant 7 (ARv7). Cancer Letters. PMID 28373004 DOI: 10.1016/J.Canlet.2017.03.035 |
0.745 |
|
| 2017 |
Guo C, Yeh S, Niu Y, Li G, Zheng J, Li L, Chang C. Targeting Androgen Receptor versus Targeting Androgens to suppress Castration Resistant Prostate Cancer. Cancer Letters. PMID 28323036 DOI: 10.1016/J.Canlet.2017.03.022 |
0.449 |
|
| 2017 |
Yue D, Wang Y, Sun Y, Niu Y, Chang C. C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion. Neoplasia (New York, N.Y.). 19: 135-144. PMID 28107702 DOI: 10.1016/J.Neo.2016.12.003 |
0.406 |
|
| 2017 |
Wang K, Sun Y, Tao W, Fei X, Chang C. Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals. Cancer Letters. PMID 28089832 DOI: 10.1016/J.Canlet.2016.12.036 |
0.385 |
|
| 2017 |
Wu G, Sun Y, Chang C, Wu D. MP99-17 CIRCULARRNA-C17 ALTERS THE ANTI ANDROGEN-ENZALUTAMIDE RESISTANCE IN CASTRATION-RESISTANT PROSTATE CANCER VIA REGULATING ANDROGEN RECEPTOR VARIANT ARV7 EXPRESSION Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.3103 |
0.418 |
|
| 2017 |
Yang Y, Yeh C, Slavin S, Luo J, Chou F, Wang K, Truong M, Chang C, Messing EM, Yeh S. MP87-13 ESTROGEN RECEPTOR α IN CANCER ASSOCIATED FIBROBLASTS SUPPRESSES PROSTATE CANCER INVASION VIA REDUCING CCL5, IL6 AND MACROPHAGE INFILTRATION IN THE TUMOR MICROENVIRONMENT. Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2717 |
0.386 |
|
| 2017 |
Shang Z, Yang Y, Truong M, Li Y, Hsu I, Tian J, Wen S, Han R, Messing EM, Chang C, Niu Y, Yeh S. MP65-12 TARGETING ESTROGEN/ESTROGEN RECEPTOR SIGNAL PATHWAYS TO ENHANCE THE EFFICACY OF BACILLUS CALMETTE-GUÉRIN TREATMENT IN BLADDER CANCER Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.2006 |
0.352 |
|
| 2016 |
Li L, Dang Q, Xie H, Yang Z, He D, Liang L, Song W, Yeh S, Chang C. Correction: Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population. Oncotarget. 7: 83828. PMID 28082728 DOI: 10.18632/oncotarget.13912 |
0.333 |
|
| 2016 |
Wang Y, Ou Z, Sun Y, Yeh S, Wang X, Long J, Chang C. Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals. Oncogene. PMID 27869170 DOI: 10.1038/Onc.2016.330 |
0.376 |
|
| 2016 |
Hu S, Li L, Yeh S, Cui Y, Li X, Chang HC, Jin J, Chang C. Corrigendum to "Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling" [Mol Oncol 9 (1) (2015) 44-57]. Molecular Oncology. PMID 27838215 DOI: 10.1016/J.Molonc.2016.10.005 |
0.451 |
|
| 2016 |
Xu J, Lin H, Li G, Sun Y, Chen J, Shi L, Cai X, Chang C. The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals. Ebiomedicine. PMID 27688096 DOI: 10.1016/J.Ebiom.2016.07.013 |
0.315 |
|
| 2016 |
Xu J, Lin H, Li G, Sun Y, Shi L, Ma WL, Chen J, Cai X, Chang C. Sorafenib with ASC-J9® synergistically suppresses the HCC progression via altering the pSTAT3-CCL2/Bcl2 signals. International Journal of Cancer. PMID 27668844 DOI: 10.1002/Ijc.30446 |
0.652 |
|
| 2016 |
Lin SJ, Chou FJ, Lin CY, Chang HC, Yeh S, Chang C. New therapy with ASC-J9® to suppress the prostatitis via altering the cytokine CCL2 signals. Oncotarget. PMID 27564257 DOI: 10.18632/Oncotarget.11484 |
0.721 |
|
| 2016 |
Tien N, Chen HC, Gau SL, Lin TH, Lin HS, You BJ, Tsai PC, Chen IR, Tsai MF, Wang IK, Chen CJ, Chang CT. Diagnosis of bacterial pathogens in the dialysate of peritoneal dialysis patients with peritonitis using surface-enhanced Raman spectroscopy. Clinica Chimica Acta; International Journal of Clinical Chemistry. PMID 27485760 DOI: 10.1016/J.Cca.2016.07.026 |
0.549 |
|
| 2016 |
Chang CC, Hsu CY, Huang PH, Chiang CH, Huang SS, Leu HB, Huang CC, Chen JW, Lin SJ. Association of Serum Bilirubin with SYNTAX Score and Future Cardiovascular Events in Patients Undergoing Coronary Intervention. Acta Cardiologica Sinica. 32: 412-9. PMID 27471354 |
0.608 |
|
| 2016 |
Shen JH, Chang CC, Chen YT, Hsih CJ, Huang H, Lin BS. Using a Low Fluence Q-Switched 532/1064-nm Nd: YAG Laser for Facial Skin Depigmentation in Asian Patients: Outcome and Complication Profile Analysis. Annals of Plastic Surgery. PMID 27404474 DOI: 10.1097/SAP.0000000000000844 |
0.571 |
|
| 2016 |
Cui Y, Sun Y, Hu S, Luo J, Li L, Li X, Yeh S, Jin J, Chang C. Neuroendocrine prostate cancer (NEPCa) increased the neighboring PCa chemoresistance via altering the PTHrP/p38/Hsp27/androgen receptor (AR)/p21 signals. Oncogene. PMID 27375022 DOI: 10.1038/Onc.2016.135 |
0.467 |
|
| 2016 |
Lai HC, Yeh CC, Jeng LB, Huang SF, Liao PY, Lei FJ, Cheng WC, Hsu CL, Cai X, Chang C, Ma WL. Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells. Oncotarget. PMID 27340775 DOI: 10.18632/Oncotarget.10186 |
0.769 |
|
| 2016 |
Fan W, Xie S, Zhao X, Li N, Chang C, Li L, Yu G, Chi X, Pan Y, Niu J, Zhong J, Sun B. IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis C through long-term induction of USP18. The Journal of General Virology. PMID 27302182 DOI: 10.1099/Jgv.0.000522 |
0.652 |
|
| 2016 |
Hsu CL, Hsu CW, Chang PC, Huang WH, Weng CH, Yang HY, Liu SH, Chen KH, Weng SM, Chang CC, Wang IK, Tsai AI, Yen TH. Oral Tori in Chronic Peritoneal Dialysis Patients. Plos One. 11: e0156988. PMID 27275607 DOI: 10.1371/journal.pone.0156988 |
0.526 |
|
| 2016 |
Wang R, Lin W, Lin C, Li L, Sun Y, Chang C. ASC-J9(®) suppresses castration resistant prostate cancer progression via degrading the enzalutamide-induced androgen receptor mutant AR-F876L. Cancer Letters. PMID 27233475 DOI: 10.1016/J.Canlet.2016.05.018 |
0.441 |
|
| 2016 |
Chiu CC, Chen YT, Hsu CY, Chang CC, Huang CC, Leu HB, Li SY, Kuo SC, Huang PH, Chen JW, Lin SJ. Association between previous history of gout attack and risk of deep vein thrombosis - a nationwide population-based cohort study. Scientific Reports. 6: 26541. PMID 27231197 DOI: 10.1038/srep26541 |
0.742 |
|
| 2016 |
Chang CC, Sun JT, Liou TH, Kuo CF, Bei CH, Lin SJ, Tsai WT, Tan NC, Liou CB, Su MJ, Yen TH, Chu FY. Clinical Significance of Smudge Cells in Peripheral Blood Smears in Hematological Malignancies and Other Diseases. Asian Pacific Journal of Cancer Prevention : Apjcp. 17: 1847-50. PMID 27221863 |
0.635 |
|
| 2016 |
Chen YT, Chang CC, Hsu CR, Shen JH, Shih CJ, Lin BS. Combined vitamin C sonophoresis and neodymium-doped yttrium aluminum garnet (NdYAG) laser for facial hyperpigmentation: An outcome observation study in Asian patients. Indian Journal of Dermatology, Venereology and Leprology. PMID 27212284 |
0.574 |
|
| 2016 |
Tao L, Qiu J, Jiang M, Song W, Yeh S, Yu H, Zang L, Xia S, Chang C. Infiltrated T cells promote bladder cancer progression via increasing IL-1→androgen receptor (AR)→HIF-1α→VEGFa signals. Molecular Cancer Therapeutics. PMID 27196763 DOI: 10.1158/1535-7163.Mct-15-0306 |
0.343 |
|
| 2016 |
Chen WL, Chen YT, Huang SY, Yang CY, Wu CD, Chang CW. Landing strategies focusing on the control of tibial rotation in the initial contact period of one-leg forward hops. Scandinavian Journal of Medicine & Science in Sports. PMID 27185513 DOI: 10.1111/sms.12696 |
0.569 |
|
| 2016 |
Lin KC, Yip HK, Shao PL, Wu SC, Chen KH, Chen YT, Yang CC, Sun CK, Kao GS, Chen SY, Chai HT, Chang CL, Chen CH, Lee MS. Combination of adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes for protecting kidney from acute ischemia-reperfusion injury. International Journal of Cardiology. 216: 173-185. PMID 27156061 DOI: 10.1016/j.ijcard.2016.04.061 |
0.586 |
|
| 2016 |
Liang CT, Huang HB, Wang CC, Chen YR, Chang CF, Shiao MS, Chen YC, Lin TH. L17A/F19A Substitutions Augment the α-Helicity of β-Amyloid Peptide Discordant Segment. Plos One. 11: e0154327. PMID 27104649 DOI: 10.1371/journal.pone.0154327 |
0.562 |
|
| 2016 |
Wang KT, Lin SJ, Wang HC, Chen PC, Lin JJ, Chiang JR, Chang CL, Shih DY, Lo CF, Wang DY. Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine. Biologicals : Journal of the International Association of Biological Standardization. PMID 27068365 DOI: 10.1016/j.biologicals.2016.01.003 |
0.619 |
|
| 2016 |
Wen S, Tian J, Niu Y, Li L, Yeh S, Chang C. ASC-J9(®), and not Casodex or Enzalutamide, suppresses prostate cancer stem/progenitor cell invasion via altering the EZH2-STAT3 signals. Cancer Letters. PMID 27045473 DOI: 10.1016/J.Canlet.2016.01.057 |
0.424 |
|
| 2016 |
Chang CC, Sun JT, Chen JY, Chen YT, Li PY, Lee TC, Su MJ, Wu JM, Yen TH, Chu FY. Impact of Peri-Operative Anemia and Blood Transfusions in Patients with Gastric Cancer Receiving Gastrectomy. Asian Pacific Journal of Cancer Prevention : Apjcp. 17: 1427-31. PMID 27039784 |
0.575 |
|
| 2016 |
Lee TH, Ko TM, Chen CH, Lee MT, Chang YJ, Chang CH, Huang KL, Chang TY, Lee JD, Chang KC, Yang JT, Wen MS, Wang CY, Chen YT, Hsieh CS, et al. Identification of PTCSC3 as a Novel Locus for Large-Vessel Ischemic Stroke: A Genome-Wide Association Study. Journal of the American Heart Association. 5. PMID 27025970 DOI: 10.1161/JAHA.115.003003 |
0.561 |
|
| 2016 |
Zhai W, Sun Y, Jiang M, Wang M, Gasiewicz TA, Zheng J, Chang C. Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia. Oncogene. PMID 26973243 DOI: 10.1038/Onc.2016.19 |
0.385 |
|
| 2016 |
Chang CJ, Chen YT, Liu CS, Lin WY, Lin CL, Lin MC, Kao CH. Atrial Fibrillation Increases the Risk of Peripheral Arterial Disease With Relative Complications and Mortality: A Population-Based Cohort Study. Medicine. 95: e3002. PMID 26945422 DOI: 10.1097/MD.0000000000003002 |
0.571 |
|
| 2016 |
Shi L, Lin H, Li G, Jin RA, Xu J, Sun Y, Ma WL, Yeh S, Cai X, Chang C. Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib Plus NK Cells-Immunotherapy to Better Suppress HCC Progression. Molecular Cancer Therapeutics. PMID 26939703 DOI: 10.1158/1535-7163.Mct-15-0706 |
0.698 |
|
| 2016 |
Shen JH, Liu CJ, Lo SC, Chen YT, Chang CC. Topical Therapy As Adjuvant Treatment to Save a Limb With Critical Ischemia From Extensive and Deep Diabetic Foot Infection When Revascularization Is Not Feasible. Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society / Wocn. 43: 197-201. PMID 26938169 DOI: 10.1097/WON.0000000000000211 |
0.575 |
|
| 2016 |
Huang WC, Chen CY, Lin SJ, Chang CS. Medication adherence to oral anticancer drugs: systematic review. Expert Review of Anticancer Therapy. PMID 26935964 DOI: 10.1586/14737140.2016.1159515 |
0.612 |
|
| 2016 |
Kuo RL, Li LH, Lin SJ, Li ZH, Chen GW, Chang CK, Wang YR, Tam EH, Gong YN, Krug RM, Shih SR. The role of N-terminus-truncated NS1 proteins of influenza A virus in inhibiting IRF3 activation. Journal of Virology. PMID 26912617 DOI: 10.1128/Jvi.02843-15 |
0.635 |
|
| 2016 |
Lin HY, Chuang CK, Chen MR, Lin SM, Hung CL, Chang CY, Chiu PC, Tsai WH, Niu DM, Tsai FJ, Lin SJ, Hwu WL, Lin JL, Lin SP. Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II, IVA and VI. Molecular Genetics and Metabolism. PMID 26899310 DOI: 10.1016/j.ymgme.2016.02.003 |
0.61 |
|
| 2016 |
Wen S, Niu Y, Lee SO, Yeh S, Shang Z, Gao H, Li Y, Chou F, Chang C. Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells. Molecular Carcinogenesis. PMID 26894509 DOI: 10.1002/Mc.22468 |
0.483 |
|
| 2016 |
Yang CH, Chang CH, Chen TH, Fan PC, Chang SW, Chen CC, Chu PH, Chen YT, Yang HY, Yang CW, Chen YC. Combination of Urinary Biomarkers Improves Early Detection of Acute Kidney Injury in Patients With Heart Failure. Circulation Journal : Official Journal of the Japanese Circulation Society. 80: 1017-23. PMID 26888148 DOI: 10.1253/Circj.Cj-15-0886 |
0.568 |
|
| 2016 |
Shen CJ, Chang CC, Chen YT, Lai CS, Hsu YC. Melatonin Suppresses the Growth of Ovarian Cancer Cell Lines (OVCAR-429 and PA-1) and Potentiates the Effect of G1 Arrest by Targeting CDKs. International Journal of Molecular Sciences. 17. PMID 26840297 DOI: 10.3390/ijms17020176 |
0.622 |
|
| 2016 |
Shi L, Lin H, Li G, Sun Y, Shen J, Xu J, Yeh S, Cai X, Chang C. Cisplatin enhances NK cell immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals. Cancer Letters. PMID 26805759 DOI: 10.1016/J.Canlet.2016.01.017 |
0.385 |
|
| 2016 |
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Chang CP, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356 |
0.572 |
|
| 2016 |
Dong YH, Chang CH, Gagne JJ, Hsu CL, Lai MS. Comparative Cardiovascular and Cerebrovascular Safety of Inhaled Long-Acting Bronchodilators in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study. Pharmacotherapy. 36: 26-37. PMID 26799347 DOI: 10.1002/phar.1684 |
0.53 |
|
| 2016 |
Huang CK, Lee SO, Chang E, Pang H, Chang C. Androgen receptor (AR) in cardiovascular diseases. The Journal of Endocrinology. PMID 26769913 DOI: 10.1530/Joe-15-0518 |
0.702 |
|
| 2016 |
Park SS, Choi H, Kim SJ, Chang C, Kim E. CREB/GSK-3β signaling pathway regulates the expression of TR4 orphan nuclear receptor gene. Molecular and Cellular Endocrinology. PMID 26762765 DOI: 10.1016/J.Mce.2015.12.023 |
0.315 |
|
| 2016 |
Kang H, Chen Y, Huang K, Chang C. Loss of androgen receptor suppresses chondrogenic proliferation during endochondral ossification in mice Bone Abstracts. DOI: 10.1530/Boneabs.5.Op12 |
0.402 |
|
| 2015 |
Luo W, Chen Y, Wang T, Hong C, Chang LP, Chang CC, Yang YC, Xie SQ, Wang CJ. Design, synthesis and evaluation of novel 7-aminoalkyl-substituted flavonoid derivatives with improved cholinesterase inhibitory activities. Bioorganic & Medicinal Chemistry. PMID 26752094 DOI: 10.1016/j.bmc.2015.12.031 |
0.648 |
|
| 2015 |
Chang CC, Lin MS, Chen YT, Tu LT, Jane SW, Chen MY. Metabolic syndrome and health-related behaviours associated with pre-oral cancerous lesions among adults aged 20-80 years in Yunlin County, Taiwan: a cross-sectional study. Bmj Open. 5: e008788. PMID 26685025 DOI: 10.1136/bmjopen-2015-008788 |
0.587 |
|
| 2015 |
Chen CC, Su JS, Yeh HZ, Chang CS, Peng YC, Tseng CW, Chen YT, Lin CL, Kao CH. Association Between Colonic Diverticulosis and Erectile Dysfunction: A Nationwide Population-Based Study. Medicine. 94: e2042. PMID 26632705 DOI: 10.1097/MD.0000000000002042 |
0.573 |
|
| 2015 |
Rao Q, Chen Y, Yeh CR, Jie D, Li L, Chang C, Yeh S. Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals. Oncotarget. PMID 26556868 DOI: 10.18632/Oncotarget.5467 |
0.364 |
|
| 2015 |
Chen YT, Chang CC, Shen JH, Lin WN, Chen MY. Demonstrating a Conceptual Framework to Provide Efficient Wound Management Service for a Wound Care Center in a Tertiary Hospital. Medicine. 94: e1962. PMID 26554805 DOI: 10.1097/MD.0000000000001962 |
0.563 |
|
| 2015 |
Lin C, Lin W, Yeh S, Li L, Chang C. Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signals. Oncotarget. PMID 26517808 DOI: 10.18632/Oncotarget.5638 |
0.425 |
|
| 2015 |
Chang CH, Fan PC, Lin CY, Yang CH, Chen YT, Chang SW, Yang HY, Jenq CC, Hung CC, Yang CW, Chen YC. Elevation of Interleukin-18 Correlates With Cardiovascular, Cerebrovascular, and Peripheral Vascular Events: A Cohort Study of Hemodialysis Patients. Medicine. 94: e1836. PMID 26496326 DOI: 10.1097/Md.0000000000001836 |
0.575 |
|
| 2015 |
Huang WC, Tseng TY, Chen YT, Chang CC, Wang ZF, Wang CL, Hsu TN, Li PT, Chen CT, Lin JJ, Lou PJ, Chang TC. Direct evidence of mitochondrial G-quadruplex DNA by using fluorescent anti-cancer agents. Nucleic Acids Research. PMID 26487635 DOI: 10.1093/Nar/Gkv1061 |
0.618 |
|
| 2015 |
Chen BJ, Chen YT, Ullah I, Chou CH, Chan KC, Lai YL, Lin CM, Chang CM, Whang AJ. Innovative light collimator with afocal lens and total internal reflection lens for daylighting system. Applied Optics. 54: E165-70. PMID 26479648 DOI: 10.1364/AO.54.00E165 |
0.559 |
|
| 2015 |
Chang CH, Yang CH, Yang HY, Chen TH, Lin CY, Chang SW, Chen YT, Hung CC, Fang JT, Yang CW, Chen YC. Urinary Biomarkers Improve the Diagnosis of Intrinsic Acute Kidney Injury in Coronary Care Units. Medicine. 94: e1703. PMID 26448023 DOI: 10.1097/Md.0000000000001703 |
0.583 |
|
| 2015 |
Chang YS, Chang CC, Shen JH, Chen YT, Chan KK. Nonallergic Eyelid Edema After Botulinum Toxin Type A Injection: Case Report and Review of Literature. Medicine. 94: e1610. PMID 26402825 DOI: 10.1097/MD.0000000000001610 |
0.582 |
|
| 2015 |
Ko TM, Tsai CY, Chen SY, Chen KS, Yu KH, Chu CS, Huang CM, Wang CR, Weng CT, Yu CL, Hsieh SC, Tsai JC, Lai WT, Tsai WC, Yin GD, ... ... Chang CS, et al. Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study. Bmj (Clinical Research Ed.). 351: h4848. PMID 26399967 DOI: 10.1136/bmj.h4848 |
0.724 |
|
| 2015 |
Dong YH, Hsu CL, Li YY, Chang CH, Lai MS. Bronchodilators use in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease. 10: 1769-79. PMID 26366069 DOI: 10.2147/COPD.S86198 |
0.522 |
|
| 2015 |
Luo J, Lee SO, Cui Y, Yang R, Li L, Chang C. Infiltrating bone marrow mesenchymal stem cells (BM-MSCs) increase prostate cancer cell invasion via altering the CCL5/HIF2α/androgen receptor signals. Oncotarget. PMID 26342197 DOI: 10.18632/Oncotarget.4515 |
0.469 |
|
| 2015 |
Sha K, Yeh S, Chang C, Nastiuk KL, Krolewski JJ. TNF signaling mediates an enzalutamide-induced metastatic phenotype of prostate cancer and microenvironment cell co-cultures. Oncotarget. 6: 25726-40. PMID 26327448 DOI: 10.18632/Oncotarget.4535 |
0.438 |
|
| 2015 |
Huang CK, Luo J, Lai KP, Wang R, Pang H, Chang E, Yan C, Sparks J, Lee SO, Cho J, Chang C. Androgen Receptor Promotes Abdominal Aortic Aneurysm Development via Modulating Inflammatory Interleukin-1α and Transforming Growth Factor-β1 Expression. Hypertension. PMID 26324502 DOI: 10.1161/Hypertensionaha.115.05654 |
0.815 |
|
| 2015 |
Yip HK, Yang CC, Chen KH, Huang TH, Chen YL, Zhen YY, Sung PH, Chiang HJ, Sheu JJ, Chang CL, Chen CH, Chang HW, Chen YT. Combined Melatonin and Exendin-4 Therapy Preserves Renal Ultrastructural Integrity after Ischemia-Reperfusion Injury in the Male Rat. Journal of Pineal Research. PMID 26309060 DOI: 10.1111/jpi.12273 |
0.586 |
|
| 2015 |
Ou Z, Wang Y, Liu L, Li L, Yeh S, Qi L, Chang C. Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals. Oncotarget. 6: 26065-78. PMID 26305549 DOI: 10.18632/Oncotarget.4569 |
0.366 |
|
| 2015 |
Chen Y, Sun Y, Rao Q, Xu H, Li L, Chang C. Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status. Oncotarget. 6: 31203-15. PMID 26304926 DOI: 10.18632/Oncotarget.4522 |
0.331 |
|
| 2015 |
Wu CY, Lin YW, Kuo CH, Liu WH, Tai HF, Pan CH, Chen YT, Hsiao PW, Chan CH, Chang CC, Liu CC, Chow YH, Chen JR. Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic Mouse. Plos One. 10: e0136420. PMID 26287531 DOI: 10.1371/journal.pone.0136420 |
0.588 |
|
| 2015 |
Shang Z, Li Y, Zhang M, Tian J, Han R, Shyr CR, Messing E, Yeh S, Niu Y, Chang C. Anti-androgen therapy with Hydroxyflutamide or androgen receptor degradation enhancer ASC-J9® enhances BCG efficacy to better suppress bladder cancer progression. Molecular Cancer Therapeutics. PMID 26264279 DOI: 10.1158/1535-7163.Mct-14-1055-T |
0.712 |
|
| 2015 |
Song W, Li L, He D, Xie H, Chen J, Yeh CR, Chang LS, Yeh S, Chang C. Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR)→c-Myc signals. Cancer Letters. PMID 26231735 DOI: 10.1016/J.Canlet.2015.07.027 |
0.39 |
|
| 2015 |
Yu S, Wang M, Ding X, Xia L, Chen B, Chen Y, Zhang Z, Niu Y, Li G, Chang C. Testicular orphan nuclear receptor 4 is associated with the radio-sensitivity of prostate cancer. The Prostate. PMID 26178291 DOI: 10.1002/Pros.23044 |
0.42 |
|
| 2015 |
Chen PL, Shih SR, Wang PW, Lin YC, Chu CC, Lin JH, Chen SC, Chang CC, Huang TS, Tsai KS, Tseng FY, Wang CY, Lu JY, Chiu WY, Chang CC, et al. Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study. Nature Communications. 6: 7633. PMID 26151496 DOI: 10.1038/Ncomms8633 |
0.574 |
|
| 2015 |
Wen S, Niu Y, Yeh S, Chang C. BM-MSCs promote prostate cancer progression via the conversion of normal fibroblasts to cancer-associated fibroblasts. International Journal of Oncology. PMID 26095189 DOI: 10.3892/Ijo.2015.3060 |
0.41 |
|
| 2015 |
Lin SJ, Yang DR, Li G, Chang C. TR4 Nuclear Receptor Different Roles in Prostate Cancer Progression. Frontiers in Endocrinology. 6: 78. PMID 26074876 DOI: 10.3389/Fendo.2015.00078 |
0.756 |
|
| 2015 |
Hsu CR, Chang CC, Chen YT, Lin WN, Chen MY. Organization of wound healing services: The impact on lowering the diabetes foot amputation rate in a ten-year review and the importance of early debridement. Diabetes Research and Clinical Practice. 109: 77-84. PMID 26021976 DOI: 10.1016/j.diabres.2015.04.026 |
0.57 |
|
| 2015 |
Qiu X, Zhu J, Sun Y, Fan K, Yang DR, Li G, Yang G, Chang C. TR4 nuclear receptor increases prostate cancer invasion via decreasing the miR-373-3p expression to alter TGFβR2/p-Smad3 signals. Oncotarget. PMID 25980442 DOI: 10.18632/Oncotarget.3778 |
0.381 |
|
| 2015 |
Wang RS, Chang HY, Kao SH, Kao CH, Wu YC, Yeh S, Tzeng CR, Chang C. Abnormal mitochondrial function and impaired granulosa cell differentiation in androgen receptor knockout mice. International Journal of Molecular Sciences. 16: 9831-49. PMID 25941928 DOI: 10.3390/Ijms16059831 |
0.397 |
|
| 2015 |
Xie H, Li L, Zhu G, Dang Q, Ma Z, He D, Chang L, Song W, Chang HC, Krolewski JJ, Nastiuk KL, Yeh S, Chang C. Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-β1/Smad/MMP9 signals. Oncotarget. 6: 12326-39. PMID 25940439 DOI: 10.18632/Oncotarget.3619 |
0.431 |
|
| 2015 |
Lin SJ, Lin CY, Yang DR, Izumi K, Yan E, Niu X, Chang HC, Miyamoto H, Wang N, Li G, Chang C. The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status. Neoplasia (New York, N.Y.). 17: 339-47. PMID 25925376 DOI: 10.1016/J.Neo.2015.02.005 |
0.743 |
|
| 2015 |
Li L, Dang Q, Xie H, Yang Z, He D, Liang L, Song W, Yeh S, Chang C. Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population. Oncotarget. 6: 14179-90. PMID 25895025 DOI: 10.18632/Oncotarget.3651 |
0.454 |
|
| 2015 |
Lin SJ, Yang DR, Wang N, Jiang M, Miyamoto H, Li G, Chang C. TR4 nuclear receptor enhances prostate cancer initiation via altering the stem cell population and EMT signals in the PPARG-deleted prostate cells. Oncoscience. 2: 142-50. PMID 25859557 |
0.744 |
|
| 2015 |
Zhu J, Yang DR, Sun Y, Qiu X, Chang HC, Li G, Shan Y, Chang C. TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression. Molecular Cancer Therapeutics. 14: 1445-53. PMID 25833838 DOI: 10.1158/1535-7163.Mct-14-0971 |
0.45 |
|
| 2015 |
Dang Q, Li L, Xie H, He D, Chen J, Song W, Chang LS, Chang HC, Yeh S, Chang C. Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals. Molecular Oncology. PMID 25817444 DOI: 10.1016/J.Molonc.2015.02.010 |
0.441 |
|
| 2015 |
Lee MF, Chang CW, Song PP, Hwang GY, Lin SJ, Chen YH. IgE-Binding Epitope Mapping and Tissue Localization of the Major American Cockroach Allergen Per a 2. Allergy, Asthma & Immunology Research. 7: 376-83. PMID 25749772 DOI: 10.4168/aair.2015.7.4.376 |
0.624 |
|
| 2015 |
Tsai MS, Lee ML, Chang CY, Fan HH, Yu IS, Chen YT, You JY, Chen CY, Chang FC, Hsiao JH, Khorkova O, Liou HH, Yanagawa Y, Lee LJ, Lin SW. Functional and structural deficits of the dentate gyrus network coincide with emerging spontaneous seizures in an Scn1a mutant Dravet Syndrome model during development. Neurobiology of Disease. 77: 35-48. PMID 25725421 DOI: 10.1016/J.Nbd.2015.02.010 |
0.593 |
|
| 2015 |
Lin TH, Lung CC, Su HP, Huang JY, Ko PC, Jan SR, Sun YH, Nfor ON, Tu HP, Chang CS, Jian ZH, Chiang YC, Liaw YP. Association between periodontal disease and osteoporosis by gender: a nationwide population-based cohort study. Medicine. 94: e553. PMID 25700325 DOI: 10.1097/MD.0000000000000553 |
0.555 |
|
| 2015 |
Ding X, Yang DR, Xia L, Chen B, Yu S, Niu Y, Wang M, Li G, Chang C. Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals. Molecular Cancer. 14: 16. PMID 25623427 DOI: 10.1186/S12943-014-0281-1 |
0.394 |
|
| 2015 |
Chen YH, Chen CJ, Lin YN, Wu YC, Hsieh WT, Wu BT, Ma WL, Chen WC, Tsai KS, Wu SY, Chang C, Chen HY, Yeh S. Proteomic analysis of urethral protein expression in an estrogen receptor α-deficient murine model of stress urinary incontinence. World Journal of Urology. PMID 25577129 DOI: 10.1007/S00345-014-1474-3 |
0.673 |
|
| 2015 |
Chang CK, Chen WA, Sie CY, Lin SC, Lin LT, Lin TH, Hsu CC, Wang SS. Investigating the effects of plasma pretreatment on the formation of ordered aggregates of lysozyme. Colloids and Surfaces. B, Biointerfaces. 126: 154-61. PMID 25561414 DOI: 10.1016/j.colsurfb.2014.12.017 |
0.558 |
|
| 2015 |
Chang CC, Chiu CC, Chiang CH, Huang CC, Chan WL, Huang PH, Chen YC, Chen TJ, Chung CM, Lin SJ, Chen JW, Leu HB. Obstructive sleep apnea and the risk of ischemic stroke in patients with atrial fibrillation. International Journal of Cardiology. 181: 144-6. PMID 25497540 DOI: 10.1016/j.ijcard.2014.12.019 |
0.592 |
|
| 2015 |
Wen S, Chang HC, Tian J, Shang Z, Niu Y, Chang C. Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer. The American Journal of Pathology. 185: 293-301. PMID 25432062 DOI: 10.1016/J.Ajpath.2014.10.012 |
0.447 |
|
| 2015 |
Lo CJ, Wang CC, Huang HB, Chang CF, Shiao MS, Chen YC, Lin TH. The Arctic mutation accelerates Aβ aggregation in SDS through reducing the helical propensity of residues 15-25. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 22: 8-18. PMID 25376379 DOI: 10.3109/13506129.2014.980943 |
0.562 |
|
| 2015 |
Chan PC, Wu CY, Chou LS, Ho CH, Chang CW, Chiou SH, Lin WJ, Chen FD, Chang CA, Hwang JJ, Liu RS, Wang HE. Monitoring Tumor Response After Histone Deacetylase Inhibitor Treatment Using 3'-Deoxy-3'-[18F]-fluorothymidine PET. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 17: 394-402. PMID 25323103 DOI: 10.1007/s11307-014-0774-8 |
0.595 |
|
| 2015 |
Lo CJ, Chyan CL, Chen YC, Chang CF, Huang HB, Lin TH. Resonance assignments and secondary structure of apolipoprotein E C-terminal domain in DHPC micelles. Biomolecular Nmr Assignments. 9: 187-90. PMID 25239652 DOI: 10.1007/s12104-014-9571-1 |
0.569 |
|
| 2015 |
Hu S, Li L, Yeh S, Cui Y, Li X, Chang HC, Jin J, Chang C. Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling. Molecular Oncology. 9: 44-57. PMID 25135278 DOI: 10.1016/J.Molonc.2014.07.013 |
0.425 |
|
| 2015 |
Ding X, Yang DR, Lee SO, Chen YL, Xia L, Lin SJ, Yu S, Niu YJ, Li G, Chang C. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling. International Journal of Cancer. Journal International Du Cancer. 136: 955-64. PMID 24975468 DOI: 10.1002/Ijc.29049 |
0.754 |
|
| 2015 |
Sha K, Yeh S, Chang C, Nastiuk KL, Krolewski JJ. TNF signaling mediates an enzalutamide-induced metastatic phenotype of prostate cancer and microenvironment cell co-cultures Oncotarget. 6: 25726-25740. DOI: 10.18632/oncotarget.4535 |
0.325 |
|
| 2015 |
Lin SJ, Yang DR, Wang N, Jiang M, Miyamoto H, Li G, Chang C. TR4 nuclear receptor enhances prostate cancer initiation via altering the stem cell population and EMT signals in the PPARG-deleted prostate cells Oncoscience. 2: 142-150. DOI: 10.18632/oncoscience.121 |
0.334 |
|
| 2015 |
Yeh C, Hsu I, Miyamoto H, Wu X, Chang C, Guancial E, Messing EM, Yeh S. Mp68-13 Estrogen Receptor Alpha Prevents Bladder Cancer Via Inpp4B Inhibited Akt Pathway In Vitro And In Vivo The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.2475 |
0.343 |
|
| 2015 |
Hu S, Cui Y, Li X, Yeh S, Jin J, Guo Y, Chang C. Mp37-03 Infiltrating Neutrophils Promote Prostate Cancer Proliferation Via Alteration Of Il8-Androgen Receptor Signaling The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1266 |
0.415 |
|
| 2015 |
Alawad A, Altuwaijri S, Aljarbu A, Kryczek I, Niu Y, Al-Sobayil FA, Chang C, Bayoumi A, Zou W, Rudat V, Hammad M. Depletion of androgen receptor (AR) in mesenchymal stem cells (MSCs) inhibits induction of CD4+CD25+FOX3+ regulatory T (Treg) cells via androgen TGF-β interaction Journal of Applied Biomedicine. 13: 263-271. DOI: 10.1016/J.Jab.2015.06.002 |
0.677 |
|
| 2014 |
Izumi K, Li L, Chang C. Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer. Clinical Investigation. 4: 935-950. PMID 26594314 DOI: 10.4155/Cli.14.77 |
0.429 |
|
| 2014 |
Chen YT, Yang CC, Sun CK, Chiang HJ, Chen YL, Sung PH, Zhen YY, Huang TH, Chang CL, Chen HH, Chang HW, Yip HK. Extracorporeal shock wave therapy ameliorates cyclophosphamide-induced rat acute interstitial cystitis though inhibiting inflammation and oxidative stress-in vitro and in vivo experiment studies. American Journal of Translational Research. 6: 631-48. PMID 25628776 |
0.58 |
|
| 2014 |
Peng YK, Lui CN, Lin TH, Chang C, Chou PT, Yung KK, Tsang SC. Multifunctional silica-coated iron oxide nanoparticles: a facile four-in-one system for in situ study of neural stem cell harvesting. Faraday Discussions. 175: 13-26. PMID 25355610 DOI: 10.1039/C4Fd00132J |
0.582 |
|
| 2014 |
Lee MF, Chang CW, Wang NM, Lin SJ, Chen YH. Serine protease inhibitor gabexate mesilate attenuates american cockroach-induced bronchial damage and inflammatory cytokine release. Journal of Investigational Allergology & Clinical Immunology. 24: 338-45. PMID 25345304 |
0.659 |
|
| 2014 |
Chang CH, Hsiso HC, Chang CM, Wang CY, Lin TH, Chen YY, Lai YL, Yen CJ, Chen KY, Whang AJ. Heliostat design for the daylighting system. Applied Optics. 53: H165-9. PMID 25322415 |
0.547 |
|
| 2014 |
Chen YH, Chen CJ, Yeh S, Lin YN, Wu YC, Hsieh WT, Wu BT, Ma WL, Chen WC, Chang C, Chen HY. Urethral dysfunction in female mice with estrogen receptor β deficiency. Plos One. 9: e109058. PMID 25275480 DOI: 10.1371/Journal.Pone.0109058 |
0.683 |
|
| 2014 |
Cheng YY, Lin SJ, Chang CH, Lin CJ, Tsai CC, Su YC. Cool extremities, a diagnostic sign recorded in Shang Han Lun, still good prognosis index for septic patients in today's medical intensive care unit. Chinese Journal of Integrative Medicine. PMID 25253547 DOI: 10.1007/s11655-014-1840-4 |
0.606 |
|
| 2014 |
Yu IC, Lin HY, Sparks JD, Yeh S, Chang C. Androgen receptor roles in insulin resistance and obesity in males: the linkage of androgen-deprivation therapy to metabolic syndrome. Diabetes. 63: 3180-8. PMID 25249645 DOI: 10.2337/Db13-1505 |
0.411 |
|
| 2014 |
Tai CM, Huang CK, Tu HP, Hwang JC, Chang CY, Yu ML. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease. Surgery For Obesity and Related Diseases : Official Journal of the American Society For Bariatric Surgery. PMID 25240529 DOI: 10.1016/j.soard.2014.07.016 |
0.573 |
|
| 2014 |
Xu D, Lin TH, Yeh CR, Cheng MA, Chen LM, Chang C, Yeh S. The wedelolactone derivative inhibits estrogen receptor-mediated breast, endometrial, and ovarian cancer cells growth. Biomed Research International. 2014: 713263. PMID 25221777 DOI: 10.1155/2014/713263 |
0.666 |
|
| 2014 |
Chang CM, Yin WY, Su YC, Wei CK, Lee CH, Juang SY, Chen YT, Chen JC, Lee CC. Preoperative risk score predicting 90-day mortality after liver resection in a population-based study. Medicine. 93: e59. PMID 25211044 DOI: 10.1097/MD.0000000000000059 |
0.577 |
|
| 2014 |
Huang CK, Lee SO, Luo J, Wang R, Dang Q, Chang C. A mouse model of liver injury to evaluate paracrine and endocrine effects of bone marrow mesenchymal stem cells. Methods in Molecular Biology (Clifton, N.J.). 1213: 69-79. PMID 25173375 DOI: 10.1007/978-1-4939-1453-1_7 |
0.627 |
|
| 2014 |
Huang CP, Hsieh TF, Chen CC, Hung XF, Yu AL, Chang C, Shyr CR. Anabolic androgens affect the competitive interactions in cell migration and adhesion between normal mouse urothelial cells and urothelial carcinoma cells. Biochemical and Biophysical Research Communications. 452: 322-7. PMID 25159849 DOI: 10.1016/J.Bbrc.2014.08.039 |
0.682 |
|
| 2014 |
Wu S, Chen Y, Fajobi T, DiVall SA, Chang C, Yeh S, Wolfe A. Conditional knockout of the androgen receptor in gonadotropes reveals crucial roles for androgen in gonadotropin synthesis and surge in female mice. Molecular Endocrinology (Baltimore, Md.). 28: 1670-81. PMID 25157703 DOI: 10.1210/Me.2014-1154 |
0.374 |
|
| 2014 |
Chen YT, Chiang HJ, Chen CH, Sung PH, Lee FY, Tsai TH, Chang CL, Chen HH, Sun CK, Leu S, Chang HW, Yang CC, Yip HK. Melatonin treatment further improves adipose-derived mesenchymal stem cell therapy for acute interstitial cystitis in rat. Journal of Pineal Research. 57: 248-61. PMID 25132326 DOI: 10.1111/jpi.12164 |
0.605 |
|
| 2014 |
Hsu CL, Liu JS, Wu PL, Guan HH, Chen YL, Lin AC, Ting HJ, Pang ST, Yeh SD, Ma WL, Chen CJ, Wu WG, Chang C. Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis. Molecular Oncology. 8: 1575-87. PMID 25091737 DOI: 10.1016/J.Molonc.2014.06.009 |
0.808 |
|
| 2014 |
Wu CY, Chang CY, Ma HH, Wang CW, Chen YT, Hsiao PW, Chang CC, Chan CH, Liu CC, Chen JR. Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses. Vaccine. 32: 4485-94. PMID 24962757 DOI: 10.1016/j.vaccine.2014.06.043 |
0.57 |
|
| 2014 |
Liang L, Li L, Tian J, Lee SO, Dang Q, Huang CK, Yeh S, Erturk E, Bushinsky D, Chang LS, He D, Chang C. Androgen receptor enhances kidney stone-CaOx crystal formation via modulation of oxalate biosynthesis & oxidative stress. Molecular Endocrinology (Baltimore, Md.). 28: 1291-303. PMID 24956378 DOI: 10.1210/Me.2014-1047 |
0.678 |
|
| 2014 |
Ma WL, Jeng LB, Lai HC, Liao PY, Chang C. Androgen receptor enhances cell adhesion and decreases cell migration via modulating β1-integrin-AKT signaling in hepatocellular carcinoma cells. Cancer Letters. 351: 64-71. PMID 24944078 DOI: 10.1016/J.Canlet.2014.05.017 |
0.688 |
|
| 2014 |
He D, Li L, Zhu G, Liang L, Guan Z, Chang L, Chen Y, Yeh S, Chang C. ASC-J9 suppresses renal cell carcinoma progression by targeting an androgen receptor-dependent HIF2α/VEGF signaling pathway. Cancer Research. 74: 4420-30. PMID 24924778 DOI: 10.1158/0008-5472.Can-13-2681 |
0.389 |
|
| 2014 |
Wang KL, Wu CH, Wang KF, Chang CC, Chen LC, Lu TM, Lin SJ, Chiang CE. The association between low-density lipoprotein cholesterol goal attainment, physician and patient attitudes and perceptions, and healthcare policy. Journal of Atherosclerosis and Thrombosis. 21: 1044-54. PMID 24882620 DOI: DN/JST.JSTAGE/jat/24158 |
0.603 |
|
| 2014 |
Lin WY, Chang CL, Fu LS, Lin CH, Lin HK. Systemic lupus erythematosus and thyroid disease: A 10-year study. Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi. PMID 24874431 DOI: 10.1016/j.jmii.2014.03.004 |
0.465 |
|
| 2014 |
Lin TH, Lai WT, Kuo CT, Hwang JJ, Chiang FT, Chang SC, Chang CJ. Additive effect of in-hospital TIMI bleeding and chronic kidney disease on 1-year cardiovascular events in patients with acute coronary syndrome : Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry. Heart and Vessels. PMID 24802367 DOI: 10.1007/s00380-014-0504-9 |
0.558 |
|
| 2014 |
Chen HH, Lin KC, Wallace CG, Chen YT, Yang CC, Leu S, Chen YC, Sun CK, Tsai TH, Chen YL, Chung SY, Chang CL, Yip HK. Additional benefit of combined therapy with melatonin and apoptotic adipose-derived mesenchymal stem cell against sepsis-induced kidney injury. Journal of Pineal Research. 57: 16-32. PMID 24761983 DOI: 10.1111/jpi.12140 |
0.601 |
|
| 2014 |
Lin TH, Hsin HT, Wang CL, Lai WT, Li AH, Kuo CT, Hwang JJ, Chiang FT, Chang SC, Chang CJ. Impact of impaired glomerular filtration rate and revascularization strategy on one-year cardiovascular events in acute coronary syndrome: data from Taiwan acute coronary syndrome full spectrum registry. Bmc Nephrology. 15: 66. PMID 24758190 DOI: 10.1186/1471-2369-15-66 |
0.55 |
|
| 2014 |
Huang CK, Luo J, Lee SO, Chang C. Concise review: androgen receptor differential roles in stem/progenitor cells including prostate, embryonic, stromal, and hematopoietic lineages. Stem Cells (Dayton, Ohio). 32: 2299-308. PMID 24740898 DOI: 10.1002/Stem.1722 |
0.707 |
|
| 2014 |
Lin SJ, Zhang Y, Liu NC, Yang DR, Li G, Chang C. Minireview: Pathophysiological roles of the TR4 nuclear receptor: Lessons learned from mice lacking TR4 Molecular Endocrinology. 28: 805-821. PMID 24702179 DOI: 10.1210/Me.2013-1422 |
0.822 |
|
| 2014 |
Huang CK, Pang H, Wang L, Niu Y, Luo J, Chang E, Sparks JD, Lee SO, Chang C. New therapy via targeting androgen receptor in monocytes/macrophages to battle atherosclerosis. Hypertension. 63: 1345-53. PMID 24688120 DOI: 10.1161/Hypertensionaha.113.02804 |
0.693 |
|
| 2014 |
Hu S, Yu W, Lv T, Chang C, Li X, Jin J. Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells. Molecular Membrane Biology. 31: 103-110. PMID 24650126 DOI: 10.3109/09687688.2014.894211 |
0.366 |
|
| 2014 |
Liu S, Lin SJ, Li G, Kim E, Chen YT, Yang DR, Tan MH, Yong EL, Chang C. Differential roles of PPARγ vs TR4 in prostate cancer and metabolic diseases. Endocrine-Related Cancer. 21: R279-300. PMID 24623743 DOI: 10.1530/Erc-13-0529 |
0.825 |
|
| 2014 |
Lu YC, Chen CN, Chu CY, Lu J, Wang BJ, Chen CH, Huang MC, Lin TH, Pan CC, Chen SS, Hsu WM, Liao YF, Wu PY, Hsia HY, Chang CC, et al. Calreticulin activates β1 integrin via fucosylation by fucosyltransferase 1 in J82 human bladder cancer cells. The Biochemical Journal. 460: 69-78. PMID 24593306 DOI: 10.1042/BJ20131424 |
0.644 |
|
| 2014 |
Lin SJ, Lee SO, Lee YF, Miyamoto H, Yang DR, Li G, Chang C. TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage/repair system. Carcinogenesis. 35: 1399-406. PMID 24583925 DOI: 10.1093/Carcin/Bgu052 |
0.754 |
|
| 2014 |
Ma WL, Lai HC, Yeh S, Cai X, Chang C. Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis. Endocrine-Related Cancer. 21: R165-82. PMID 24424503 DOI: 10.1530/Erc-13-0283 |
0.695 |
|
| 2014 |
Wang KL, Liu CJ, Chao TF, Chen SJ, Wu CH, Huang CM, Chang CC, Wang KF, Chen TJ, Lin SJ, Chiang CE. Risk of new-onset diabetes mellitus versus reduction in cardiovascular events with statin therapy. The American Journal of Cardiology. 113: 631-6. PMID 24360773 DOI: 10.1016/j.amjcard.2013.10.043 |
0.611 |
|
| 2014 |
Wang KF, Chang CC, Wang KL, Wu CH, Chen LC, Lu TM, Lin SJ, Chiang CE. Determinants of low-density lipoprotein cholesterol goal attainment: Insights from the CEPHEUS Pan-Asian Survey. Journal of the Chinese Medical Association : Jcma. 77: 61-7. PMID 24332414 DOI: 10.1016/j.jcma.2013.10.013 |
0.602 |
|
| 2014 |
Zhu G, Liang L, Li L, Dang Q, Song W, Yeh S, He D, Chang C. The expression and evaluation of androgen receptor in human renal cell carcinoma. Urology. 83: 510.e19-24. PMID 24332122 DOI: 10.1016/J.Urology.2013.10.022 |
0.385 |
|
| 2014 |
Shang Z, Niu Y, Cai Q, Chen J, Tian J, Yeh S, Lai KP, Chang C. Human kallikrein 2 (KLK2) promotes prostate cancer cell growth via function as a modulator to promote the ARA70-enhanced androgen receptor transactivation. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 35: 1881-90. PMID 24122203 DOI: 10.1007/S13277-013-1253-6 |
0.772 |
|
| 2014 |
Soh SF, Huang CK, Lee SO, Xu D, Yeh S, Li J, Yong EL, Gong Y, Chang C. Determination of androgen receptor degradation enhancer ASC-J9(®) in mouse sera and organs with liquid chromatography tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 88: 117-22. PMID 24042123 DOI: 10.1016/J.Jpba.2013.08.020 |
0.674 |
|
| 2014 |
Hsu C, Tsou HH, Lin SJ, Wang MC, Yao M, Hwang WL, Kao WY, Chiu CF, Lin SF, Lin J, Chang CS, Tien HF, Liu TW, Chen PJ, Cheng AL. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study Hepatology. 59: 2092-2100. PMID 24002804 DOI: 10.1002/hep.26718 |
0.611 |
|
| 2014 |
Wen S, Niu Y, Lee SO, Chang C. Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death. Cancer Treatment Reviews. 40: 31-40. PMID 23993415 DOI: 10.1016/J.Ctrv.2013.07.008 |
0.46 |
|
| 2014 |
Chang C, Lee SO, Yeh S, Chang TM. Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Oncogene. 33: 3225-34. PMID 23873027 DOI: 10.1038/Onc.2013.274 |
0.453 |
|
| 2014 |
Luo J, Ok Lee S, Liang L, Huang CK, Li L, Wen S, Chang C. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling. Oncogene. 33: 2768-78. PMID 23792449 DOI: 10.1038/Onc.2013.233 |
0.714 |
|
| 2014 |
He D, Li L, Zhu G, Liang L, Guan Z, Chang L, Chen Y, Yeh S, Chang C. AB130. ASC-J9 suppresses renal cell carcinoma progression by targeting an androgen receptor-dependent HIF2α/VEGF signaling pathway. Translational Andrology and Urology. 3: 130. DOI: 10.3978/J.Issn.2223-4683.2014.S130 |
0.396 |
|
| 2014 |
Yeh C, Slavin S, Da J, Chang C, Messing EM, Miyamoto H, Yeh S. MP52-13 ESTROGEN RECEPTOR α IN CANCER ASSOCIATED FIBROBLASTS SUPPRESSES PROSTATE CANCER INVASION VIA MODULATION OF THROMBOSPONDIN-2 AND MATRIX METALLOPROTEINASE 3 Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1623 |
0.417 |
|
| 2014 |
Yeh C, Hsu I, Slavin S, Chang C, Messing EM, Miyamoto H, Yeh S. MP34-02 ESTROGEN RECEPTOR ALPHA PREVENTS BLADDER CANCER VIA INPP4B/AKT PATHWAY: IN VIVO KNOCKOUT MOUSE EVIDENCE AND HUMAN TISSUE ANALYSIS Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.1015 |
0.336 |
|
| 2013 |
Chang C, Yeh S, Lee SO, Chang TM. Androgen receptor (AR) pathophysiological roles in androgen-related diseases in skin, bone/muscle, metabolic syndrome and neuron/immune systems: lessons learned from mice lacking AR in specific cells. Nuclear Receptor Signaling. 11: e001. PMID 24653668 DOI: 10.1621/Nrs.11001 |
0.431 |
|
| 2013 |
Izumi K, Chang C. Targeting inflammatory cytokines-androgen receptor (AR) signaling with ASC-J9(®) to better battle prostate cancer progression. Oncoimmunology. 2: e26853. PMID 24498558 DOI: 10.4161/Onci.26853 |
0.444 |
|
| 2013 |
Lee YK, Lin TH, Chang CF, Lo YL. Galectin-3 silencing inhibits epirubicin-induced ATP binding cassette transporters and activates the mitochondrial apoptosis pathway via β-catenin/GSK-3β modulation in colorectal carcinoma. Plos One. 8: e82478. PMID 24303084 DOI: 10.1371/journal.pone.0082478 |
0.609 |
|
| 2013 |
Lin SJ, Cheng YY, Chang CH, Lee CH, Huang YC, Su YC. Traditional chinese medicine diagnosis "yang-xu zheng": significant prognostic predictor for patients with severe sepsis and septic shock. Evidence-Based Complementary and Alternative Medicine : Ecam. 2013: 759748. PMID 24282436 DOI: 10.1155/2013/759748 |
0.614 |
|
| 2013 |
Hsieh TF, Chen CC, Ma WL, Chuang WM, Hung XF, Tsai YR, Lin MH, Zhang Q, Zhang C, Chang C, Shyr CR. Epidermal growth factor enhances androgen receptor‑mediated bladder cancer progression and invasion via potentiation of AR transactivation. Oncology Reports. 30: 2917-22. PMID 24126741 DOI: 10.3892/Or.2013.2792 |
0.834 |
|
| 2013 |
Lan KC, Chen YT, Chang C, Chang YC, Lin HJ, Huang KE, Kang HY. Up-regulation of SOX9 in sertoli cells from testiculopathic patients accounts for increasing anti-mullerian hormone expression via impaired androgen receptor signaling. Plos One. 8: e76303. PMID 24098470 DOI: 10.1371/Journal.Pone.0076303 |
0.405 |
|
| 2013 |
Izumi K, Fang LY, Mizokami A, Namiki M, Li L, Lin WJ, Chang C. Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation. Embo Molecular Medicine. 5: 1383-401. PMID 23982944 DOI: 10.1002/Emmm.201202367 |
0.748 |
|
| 2013 |
Lin TH, Izumi K, Lee SO, Lin WJ, Yeh S, Chang C. Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling. Cell Death & Disease. 4: e764. PMID 23928703 DOI: 10.1038/cddis.2013.270 |
0.816 |
|
| 2013 |
Yu S, Xia S, Yang D, Wang K, Yeh S, Gao Z, Chang C. Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion. Medical Oncology (Northwood, London, England). 30: 674. PMID 23925662 DOI: 10.1007/S12032-013-0674-9 |
0.465 |
|
| 2013 |
Huang CH, Chen CJ, Yen CT, Yu CP, Huang PN, Kuo RL, Lin SJ, Chang CK, Shih SR. Caspase-1 deficient mice are more susceptible to influenza A virus infection with PA variation. The Journal of Infectious Diseases. 208: 1898-905. PMID 23901080 DOI: 10.1093/infdis/jit381 |
0.622 |
|
| 2013 |
Lai KP, Huang CK, Fang LY, Izumi K, Lo CW, Wood R, Kindblom J, Yeh S, Chang C. Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH). Molecular Endocrinology (Baltimore, Md.). 27: 1617-31. PMID 23893956 DOI: 10.1210/Me.2013-1207 |
0.839 |
|
| 2013 |
Fang LY, Izumi K, Lai KP, Liang L, Li L, Miyamoto H, Lin WJ, Chang C. Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling. Cancer Research. 73: 5633-46. PMID 23878190 DOI: 10.1158/0008-5472.Can-12-3228 |
0.83 |
|
| 2013 |
Huang CK, Lai KP, Luo J, Tsai MY, Kang HY, Chen Y, Lee SO, Chang C. Loss of androgen receptor promotes adipogenesis but suppresses osteogenesis in bone marrow stromal cells. Stem Cell Research. 11: 938-50. PMID 23859805 DOI: 10.1016/J.Scr.2013.06.001 |
0.819 |
|
| 2013 |
Tai CM, Lin HY, Yen YC, Huang CK, Hsu WL, Huang YW, Chang CY, Wang HP, Mo LR. Effectiveness of intragastric balloon treatment for obese patients: one-year follow-up after balloon removal. Obesity Surgery. 23: 2068-74. PMID 23832520 DOI: 10.1007/s11695-013-1027-7 |
0.559 |
|
| 2013 |
Chang C, Lee SO, Wang RS, Yeh S, Chang TM. Androgen receptor (AR) physiological roles in male and female reproductive systems: lessons learned from AR-knockout mice lacking AR in selective cells. Biology of Reproduction. 89: 21. PMID 23782840 DOI: 10.1095/Biolreprod.113.109132 |
0.403 |
|
| 2013 |
Wen S, Shang Z, Zhu S, Chang C, Niu Y. Androgen receptor enhances entosis, a non-apoptotic cell death, through modulation of Rho/ROCK pathway in prostate cancer cells. The Prostate. 73: 1306-15. PMID 23775364 DOI: 10.1002/Pros.22676 |
0.434 |
|
| 2013 |
Chen CC, Hsieh TF, Chang CH, Ma WL, Hung XF, Tsai YR, Lin MH, Zhang C, Chang C, Shyr CR. Androgen receptor promotes the migration and invasion of upper urinary tract urothelial carcinoma cells through the upregulation of MMP-9 and COX-2. Oncology Reports. 30: 979-85. PMID 23715826 DOI: 10.3892/Or.2013.2506 |
0.817 |
|
| 2013 |
Lin TH, Lee SO, Niu Y, Xu D, Liang L, Li L, Yeh SD, Fujimoto N, Yeh S, Chang C. Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis. The Journal of Biological Chemistry. 288: 19359-69. PMID 23687298 DOI: 10.1074/Jbc.M113.477216 |
0.711 |
|
| 2013 |
Chang MY, Yang YJ, Chang CH, Tang AC, Liao WY, Cheng FY, Yeh CS, Lai JJ, Stayton PS, Hsieh PC. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction. Journal of Controlled Release : Official Journal of the Controlled Release Society. 170: 287-94. PMID 23665256 DOI: 10.1016/j.jconrel.2013.04.022 |
0.725 |
|
| 2013 |
Yang HT, Sheen YJ, Kao CD, Chang CA, Hu YC, Lin JL. Association between the characteristics of metabolic syndrome and Alzheimer's disease. Metabolic Brain Disease. 28: 597-604. PMID 23644927 DOI: 10.1007/s11011-013-9406-2 |
0.561 |
|
| 2013 |
Chen SH, Kuo YT, Cheng TL, Chen CY, Chiu YY, Lai JJ, Chang CC, Jaw TS, Wang YM, Liu GC. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent. The Kaohsiung Journal of Medical Sciences. 29: 246-53. PMID 23639510 DOI: 10.1016/j.kjms.2012.09.002 |
0.727 |
|
| 2013 |
Yang DR, Ding XF, Luo J, Shan YX, Wang R, Lin SJ, Li G, Huang CK, Zhu J, Chen Y, Lee SO, Chang C. Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer. The Journal of Biological Chemistry. 288: 16476-83. PMID 23609451 DOI: 10.1074/Jbc.M112.448142 |
0.809 |
|
| 2013 |
Hsieh TF, Chen CC, Yu AL, Ma WL, Zhang C, Shyr CR, Chang C. Androgen receptor decreases the cytotoxic effects of chemotherapeutic drugs in upper urinary tract urothelial carcinoma cells. Oncology Letters. 5: 1325-1330. PMID 23599788 DOI: 10.3892/Ol.2013.1140 |
0.813 |
|
| 2013 |
Hsu CL, Chang CH, Lin JW, Wu LC, Chuang LM, Lai MS. Histamine-2 receptor antagonists and risk of lung cancer in diabetic patients – an exploratory analysis. Pharmacoepidemiology and Drug Safety. 22: 632-40. PMID 23576472 DOI: 10.1002/pds.3441 |
0.583 |
|
| 2013 |
Izumi K, Mizokami A, Lin WJ, Lai KP, Chang C. Androgen receptor roles in the development of benign prostate hyperplasia. The American Journal of Pathology. 182: 1942-9. PMID 23570837 DOI: 10.1016/J.Ajpath.2013.02.028 |
0.838 |
|
| 2013 |
Wang X, Lee SO, Xia S, Jiang Q, Luo J, Li L, Yeh S, Chang C. Endothelial cells enhance prostate cancer metastasis via IL-6→androgen receptor→TGF-β→MMP-9 signals. Molecular Cancer Therapeutics. 12: 1026-37. PMID 23536722 DOI: 10.1158/1535-7163.Mct-12-0895 |
0.422 |
|
| 2013 |
Yang DR, Lin SJ, Ding XF, Miyamoto H, Messing E, Li LQ, Wang N, Chang C. Higher expression of peroxisome proliferator-activated receptor γ or its activation by agonist thiazolidinedione-rosiglitazone promotes bladder cancer cell migration and invasion. Urology. 81: 1109.e1-6. PMID 23522297 DOI: 10.1016/J.Urology.2012.12.027 |
0.717 |
|
| 2013 |
Hsu JW, Hsu I, Xu D, Miyamoto H, Liang L, Wu XR, Shyr CR, Chang C. Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor. The American Journal of Pathology. 182: 1811-20. PMID 23499463 DOI: 10.1016/J.Ajpath.2013.01.018 |
0.742 |
|
| 2013 |
Hua WK, Chang YI, Yao CL, Hwang SM, Chang CY, Lin WJ. Protein arginine methyltransferase 1 interacts with and activates p38α to facilitate erythroid differentiation. Plos One. 8: e56715. PMID 23483889 DOI: 10.1371/journal.pone.0056715 |
0.654 |
|
| 2013 |
Ding XF, Yu SC, Chen BD, Lin SJ, Chang C, Li GH. Recent advances in the study of testicular nuclear receptor 4. Journal of Zhejiang University. Science. B. 14: 171-7. PMID 23463759 DOI: 10.1631/Jzus.B1200357 |
0.738 |
|
| 2013 |
Luo WY, Lin SY, Lo KW, Lu CH, Hung CL, Chen CY, Chang CC, Hu YC. Adaptive immune responses elicited by baculovirus and impacts on subsequent transgene expression in vivo. Journal of Virology. 87: 4965-73. PMID 23408634 DOI: 10.1128/JVI.03510-12 |
0.588 |
|
| 2013 |
Chang CF, Lu TM, Yang WC, Lin SJ, Lin CC, Chung MY. Gene polymorphisms of interleukin-10 and tumor necrosis factor-α are associated with contrast-induced nephropathy. American Journal of Nephrology. 37: 110-7. PMID 23363891 DOI: 10.1159/000346528 |
0.608 |
|
| 2013 |
Huang CK, Tsai MY, Luo J, Kang HY, Lee SO, Chang C. Suppression of androgen receptor enhances the self-renewal of mesenchymal stem cells through elevated expression of EGFR. Biochimica Et Biophysica Acta. 1833: 1222-34. PMID 23333872 DOI: 10.1016/J.Bbamcr.2013.01.007 |
0.695 |
|
| 2013 |
Lai KP, Lai JJ, Chang P, Altuwaijri S, Hsu JW, Chuang KH, Shyr CR, Yeh S, Chang C. Targeting thymic epithelia AR enhances T-cell reconstitution and bone marrow transplant grafting efficacy. Molecular Endocrinology (Baltimore, Md.). 27: 25-37. PMID 23250486 DOI: 10.1210/Me.2012-1244 |
0.81 |
|
| 2013 |
Tai CM, Huang CK, Lee YC, Chang CY, Lee CT, Lin JT. Increase in gastroesophageal reflux disease symptoms and erosive esophagitis 1 year after laparoscopic sleeve gastrectomy among obese adults. Surgical Endoscopy. 27: 1260-6. PMID 23232995 DOI: 10.1007/s00464-012-2593-9 |
0.56 |
|
| 2013 |
Lai KP, Huang CK, Chang YJ, Chung CY, Yamashita S, Li L, Lee SO, Yeh S, Chang C. New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells. The American Journal of Pathology. 182: 460-73. PMID 23219429 DOI: 10.1016/J.Ajpath.2012.10.029 |
0.846 |
|
| 2013 |
Huang CK, Lee SO, Lai KP, Ma WL, Lin TH, Tsai MY, Luo J, Chang C. Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis. Hepatology (Baltimore, Md.). 57: 1550-63. PMID 23150236 DOI: 10.1002/Hep.26135 |
0.802 |
|
| 2013 |
Yu IC, Lin HY, Liu NC, Sparks JD, Yeh S, Fang LY, Chen L, Chang C. Neuronal androgen receptor regulates insulin sensitivity via suppression of hypothalamic NF-κB-mediated PTP1B expression. Diabetes. 62: 411-23. PMID 23139353 DOI: 10.2337/Db12-0135 |
0.771 |
|
| 2013 |
Fang F, Zheng Q, Zhang J, Dong B, Zhu S, Huang X, Wang Y, Zhao B, Li S, Xiong H, Chen J, Wu N, Song SW, Chang C, Yang Y. Testicular orphan nuclear receptor 4-associated protein 16 promotes non-small cell lung carcinoma by activating estrogen receptor β and blocking testicular orphan nuclear receptor 2. Oncology Reports. 29: 297-305. PMID 23129017 DOI: 10.3892/Or.2012.2107 |
0.377 |
|
| 2013 |
Li L, Xie H, Liang L, Gao Y, Zhang D, Fang L, Lee SO, Luo J, Chen X, Wang X, Chang LS, Yeh S, Wang Y, He D, Chang C. Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage. Carcinogenesis. 34: 257-67. PMID 23104178 DOI: 10.1093/Carcin/Bgs337 |
0.452 |
|
| 2013 |
Hsieh TF, Chen CC, Chang CH, Yu AL, Ma WL, Shyr CR. The potential use of primary human upper urinary tract urothelial cell carcinoma (UUT-UCC) cultured cells for prognostic indicators and chemosensitivity test. Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fã¼R Toxikologische Pathologie. 65: 703-8. PMID 23069010 DOI: 10.1016/j.etp.2012.09.003 |
0.764 |
|
| 2013 |
Shih LY, Kuo MC, Kuo CY, Lin TH, Bai LY, Chen TY, Wang MC, Lin TL, Lan YJ, Chen CC, Yang Y, Hsiao PC, Lai CL, Chang CH, Lin TH. Emerging kinetics of BCR-ABL1 mutations and their effect on disease outcomes in chronic myeloid leukemia patients with imatinib failure. Leukemia Research. 37: 43-9. PMID 23062378 DOI: 10.1016/j.leukres.2012.09.012 |
0.565 |
|
| 2013 |
Shyr CR, Chen CC, Hsieh TF, Chang CH, Ma WL, Yeh S, Messing E, Li TH, Li FY, Chang C. The expression and actions of androgen receptor in upper urinary tract urothelial carcinoma (UUTUC) tissues and the primary cultured cells. Endocrine. 43: 191-9. PMID 22851332 DOI: 10.1007/S12020-012-9762-4 |
0.816 |
|
| 2013 |
Lee SO, Ma Z, Yeh CR, Luo J, Lin TH, Lai KP, Yamashita S, Liang L, Tian J, Li L, Jiang Q, Huang CK, Niu Y, Yeh S, Chang C. New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells. Journal of Molecular Cell Biology. 5: 14-26. PMID 22831834 DOI: 10.1093/Jmcb/Mjs042 |
0.808 |
|
| 2013 |
Chang CH, Yang YH, Lin SJ, Su JJ, Cheng CL, Lin LJ. Risk of insomnia attributable to β-blockers in elderly patients with newly diagnosed hypertension. Drug Metabolism and Pharmacokinetics. 28: 53-8. PMID 22813717 DOI: DN/JST.JSTAGE/dmpk/DMPK-12-RG-004 |
0.615 |
|
| 2013 |
Chang CW, Li SY, Huang SH, Huang CK, Chen YY, Chen CC. Effects of ultraviolet germicidal irradiation and swirling motion on airborne Staphylococcus aureus, Pseudomonas aeruginosa and Legionella pneumophila under various relative humidities. Indoor Air. 23: 74-84. PMID 22680348 DOI: 10.1111/j.1600-0668.2012.00793.x |
0.575 |
|
| 2013 |
Izumi K, Zheng Y, Hsu JW, Chang C, Miyamoto H. Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis. Molecular Carcinogenesis. 52: 94-102. PMID 22086872 DOI: 10.1002/Mc.21833 |
0.435 |
|
| 2013 |
liang l, li l, tian j, lee SO, dang Q, huang C, yeh S, chang LS, he d, chang C. 2300 ORGAN SPECIFIC ANDROGEN RECEPTOR KNOCKOUT MICE SUPPRESS BIOSYNTHESIZE OF OXALATE AND OXIDATIVE INJURY OF KIDNEY EPITHELIAL CELL ON THE PROCESS OF OXALATE CRYSTAL RETENTION Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.2241 |
0.664 |
|
| 2012 |
Chen SH, Kuo YT, Singh G, Cheng TL, Su YZ, Wang TP, Chiu YY, Lai JJ, Chang CC, Jaw TS, Tzou SC, Liu GC, Wang YM. Development of a Gd(III)-based receptor-induced magnetization enhancement (RIME) contrast agent for β-glucuronidase activity profiling. Inorganic Chemistry. 51: 12426-35. PMID 23116118 DOI: 10.1021/ic301827p |
0.729 |
|
| 2012 |
Tian J, Lee SO, Liang L, Luo J, Huang CK, Li L, Niu Y, Chang C. Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis. The Journal of Biological Chemistry. 287: 39954-66. PMID 23012352 DOI: 10.1074/Jbc.M112.395574 |
0.709 |
|
| 2012 |
Zhan YY, Chen Y, Zhang Q, Zhuang JJ, Tian M, Chen HZ, Zhang LR, Zhang HK, He JP, Wang WJ, Wu R, Wang Y, Shi C, Yang K, Li AZ, ... ... Chang C, et al. The orphan nuclear receptor Nur77 regulates LKB1 localization and activates AMPK. Nature Chemical Biology. 8: 897-904. PMID 22983157 DOI: 10.1038/Nchembio.1069 |
0.328 |
|
| 2012 |
Lai JJ, Lai KP, Zeng W, Chuang KH, Altuwaijri S, Chang C. Androgen receptor influences on body defense system via modulation of innate and adaptive immune systems: lessons from conditional AR knockout mice. The American Journal of Pathology. 181: 1504-12. PMID 22959669 DOI: 10.1016/J.Ajpath.2012.07.008 |
0.81 |
|
| 2012 |
Lu T, Lin WJ, Izumi K, Wang X, Xu D, Fang LY, Li L, Jiang Q, Jin J, Chang C. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development. Molecular Endocrinology (Baltimore, Md.). 26: 1707-15. PMID 22915828 DOI: 10.1210/Me.2012-1079 |
0.738 |
|
| 2012 |
Jiang Q, Yeh S, Wang X, Xu D, Zhang Q, Wen X, Xia S, Chang C. Targeting androgen receptor leads to suppression of prostate cancer via induction of autophagy. The Journal of Urology. 188: 1361-8. PMID 22906664 DOI: 10.1016/J.Juro.2012.06.004 |
0.48 |
|
| 2012 |
Gao T, Gao Y, Chang C, Chen Y, Liu M, Xie S, He K, Ma X, Zhang Y, Liu Z. Atomic-scale morphology and electronic structure of manganese atomic layers underneath epitaxial graphene on SiC(0001). Acs Nano. 6: 6562-8. PMID 22861188 DOI: 10.1021/Nn302303N |
0.625 |
|
| 2012 |
Lai JJ, Chang P, Lai KP, Chen L, Chang C. The role of androgen and androgen receptor in skin-related disorders. Archives of Dermatological Research. 304: 499-510. PMID 22829074 DOI: 10.1007/S00403-012-1265-X |
0.811 |
|
| 2012 |
Lai KP, Yamashita S, Huang CK, Yeh S, Chang C. Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines. Embo Molecular Medicine. 4: 791-807. PMID 22745041 DOI: 10.1002/Emmm.201101140 |
0.84 |
|
| 2012 |
Lin SJ, Ho HC, Lee YF, Liu NC, Liu S, Li G, Shyr CR, Chang C. Reduced osteoblast activity in the mice lacking TR4 nuclear receptor leads to osteoporosis. Reproductive Biology and Endocrinology : Rb&E. 10: 43. PMID 22676849 DOI: 10.1186/1477-7827-10-43 |
0.808 |
|
| 2012 |
Whang LM, Wu YJ, Lee YC, Chen HW, Fukushima T, Chang MY, Cheng SS, Hsu SF, Chang CH, Shen W, Huang CK, Fu R, Chang B. Nitrification performance and microbial ecology of nitrifying bacteria in a full-scale membrane bioreactor treating TFT-LCD wastewater. Bioresource Technology. 122: 70-7. PMID 22595093 DOI: 10.1016/j.biortech.2012.04.092 |
0.566 |
|
| 2012 |
Wang X, Lin WJ, Izumi K, Jiang Q, Lai KP, Xu D, Fang LY, Lu T, Li L, Xia S, Chang C. Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation. The Journal of Biological Chemistry. 287: 18376-85. PMID 22474290 DOI: 10.1074/Jbc.M112.355164 |
0.83 |
|
| 2012 |
Yan SJ, Lee YF, Ting HJ, Liu NC, Liu S, Lin SJ, Yeh SD, Li G, Chang C. Deficiency in TR4 nuclear receptor abrogates Gadd45a expression and increases cytotoxicity induced by ionizing radiation. Cellular & Molecular Biology Letters. 17: 309-22. PMID 22396141 DOI: 10.2478/S11658-012-0012-9 |
0.805 |
|
| 2012 |
Lee SO, Tian J, Huang CK, Ma Z, Lai KP, Hsiao H, Jiang M, Yeh S, Chang C. Suppressor role of androgen receptor in proliferation of prostate basal epithelial and progenitor cells. The Journal of Endocrinology. 213: 173-82. PMID 22393245 DOI: 10.1530/Joe-11-0474 |
0.835 |
|
| 2012 |
Yamashita S, Lai KP, Chuang KL, Xu D, Miyamoto H, Tochigi T, Pang ST, Li L, Arai Y, Kung HJ, Yeh S, Chang C. ASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors. Neoplasia (New York, N.Y.). 14: 74-83. PMID 22355276 DOI: 10.1593/Neo.111436 |
0.781 |
|
| 2012 |
Ma WL, Hsu CL, Yeh CC, Wu MH, Huang CK, Jeng LB, Hung YC, Lin TY, Yeh S, Chang C. Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis. Hepatology (Baltimore, Md.). 56: 176-85. PMID 22318717 DOI: 10.1002/Hep.25644 |
0.804 |
|
| 2012 |
Miyamoto H, Yao JL, Chaux A, Zheng Y, Hsu I, Izumi K, Chang C, Messing EM, Netto GJ, Yeh S. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder. Bju International. 109: 1716-26. PMID 22221549 DOI: 10.1016/J.Juro.2012.02.453 |
0.363 |
|
| 2012 |
Tai CM, Huang CK, Hwang JC, Chiang H, Chang CY, Lee CT, Yu ML, Lin JT. Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients. Obesity Surgery. 22: 1016-21. PMID 22161114 DOI: 10.1007/s11695-011-0579-7 |
0.565 |
|
| 2012 |
Xu D, Lin TH, Li S, Da J, Wen XQ, Ding J, Chang C, Yeh S. Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells. Cancer Letters. 316: 11-22. PMID 22154085 DOI: 10.1016/J.Canlet.2011.10.006 |
0.726 |
|
| 2012 |
Lai KP, Yamashita S, Vitkus S, Shyr CR, Yeh S, Chang C. Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptor. Molecular Endocrinology (Baltimore, Md.). 26: 52-66. PMID 22135068 DOI: 10.1210/Me.2011-1189 |
0.832 |
|
| 2012 |
Wu CY, Hsieh CY, Huang KE, Chang C, Kang HY. Cryptotanshinone down-regulates androgen receptor signaling by modulating lysine-specific demethylase 1 function. International Journal of Cancer. Journal International Du Cancer. 131: 1423-34. PMID 22052438 DOI: 10.1002/Ijc.27343 |
0.474 |
|
| 2012 |
Zhang QX, Zhang XY, Zhang ZM, Lu W, Liu L, Li G, Cai ZM, Gui YT, Chang C. Identification of testosterone-/androgen receptor-regulated genes in mouse Sertoli cells. Asian Journal of Andrology. 14: 294-300. PMID 22002438 DOI: 10.1038/Aja.2011.94 |
0.444 |
|
| 2012 |
Xu D, Lin TH, Zhang C, Tsai YC, Li S, Zhang J, Yin M, Yeh S, Chang C. The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells. The Prostate. 72: 803-16. PMID 21932429 DOI: 10.1002/Pros.21474 |
0.704 |
|
| 2012 |
Yu S, Yeh CR, Niu Y, Chang HC, Tsai YC, Moses HL, Shyr CR, Chang C, Yeh S. Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts. The Prostate. 72: 437-49. PMID 21739465 DOI: 10.1002/Pros.21445 |
0.755 |
|
| 2012 |
Chen W, Chang CC, Chiu HC, Shabbir A, Perng DS, Huang CK. Use of individual surgeon versus surgical team approach: surgical outcomes of laparoscopic Roux-en-Y gastric bypass in an Asian Medical Center. Surgery For Obesity and Related Diseases : Official Journal of the American Society For Bariatric Surgery. 8: 214-9. PMID 21511538 DOI: 10.1016/j.soard.2011.02.011 |
0.557 |
|
| 2012 |
Ideta R, Yeh S, Lee Y, Adachi K, Takeda H, Su C, Saltzman A, Chang C. Gene expression of the androgen repressed rat TR2 orphan receptor: a member of steroid receptor superfamily. Endocrine. 3: 277-83. PMID 21153175 DOI: 10.1007/Bf03021406 |
0.425 |
|
| 2012 |
Yeh S, Yang P, Lu H, Chang C, Wu C. Targeting androgen receptor as a new potential therapeutic approach to battle tobacco carcinogens-induced non-small cell lung cancer Journal of Translational Medicine. 10. DOI: 10.1186/1479-5876-10-S2-A8 |
0.342 |
|
| 2012 |
Huang C, Pang H, Lee SO, Chang C. 1069 THE MALE HORMONE SIGNALS IN CARDIOVASCULAR DISEASES Journal of Hypertension. 30: e311. DOI: 10.1097/01.Hjh.0000420526.77714.02 |
0.625 |
|
| 2012 |
Yamashita S, Lai K, Chuang K, Miyamoto H, Tochigi T, Pang S, Li L, Arai Y, Kung H, Yeh S, Chang C. 960 ASC-J9® SUPPRESSES CASTRATION-RESISTANT PROSTATE CANCER GROWTH VIA DEGRADATION OF FULL-LENGTH AND SPLICE VARIANT ANDROGEN RECEPTORS Journal of Urology. 187. DOI: 10.1016/J.Juro.2012.02.1059 |
0.758 |
|
| 2012 |
Lee SO, Huang CK, Jie L, Chang C. Androgen receptor-regulated genes in prostate cancer initiation versus metastasis Androgen-Responsive Genes in Prostate Cancer: Regulation, Function and Clinical Applications. 155-176. DOI: 10.1007/978-1-4614-6182-1_10 |
0.697 |
|
| 2011 |
Collins LL, Lee YF, Ting HJ, Lin WJ, Liu NC, Meshul CK, Uno H, Bao BY, Chen YT, Chang C. The roles of testicular nuclear receptor 4 (TR4) in male fertility-priapism and sexual behavior defects in TR4 knockout mice. Reproductive Biology and Endocrinology : Rb&E. 9: 138. PMID 21995792 DOI: 10.1186/1477-7827-9-138 |
0.787 |
|
| 2011 |
Liu S, Yan SJ, Lee YF, Liu NC, Ting HJ, Li G, Wu Q, Chen LM, Chang C. Testicular nuclear receptor 4 (TR4) regulates UV light-induced responses via Cockayne syndrome B protein-mediated transcription-coupled DNA repair. The Journal of Biological Chemistry. 286: 38103-8. PMID 21918225 DOI: 10.1074/Jbc.M111.259523 |
0.795 |
|
| 2011 |
Jane ZY, Chang CC, Lin HK, Liu YC, Chen WL. The association between the exacerbation of irritable bowel syndrome and menstrual symptoms in young Taiwanese women. Gastroenterology Nursing : the Official Journal of the Society of Gastroenterology Nurses and Associates. 34: 277-86. PMID 21814061 DOI: 10.1097/SGA.0b013e3182248708 |
0.468 |
|
| 2011 |
Lin TH, Yeh S, Chang C. Tissue-specific knockout of androgen receptor in mice. Methods in Molecular Biology (Clifton, N.J.). 776: 275-93. PMID 21796532 DOI: 10.1007/978-1-61779-243-4_16 |
0.703 |
|
| 2011 |
Niu Y, Wang J, Shang Z, Huang SP, Shyr CR, Yeh S, Chang C. Increased CK5/CK8-positive intermediate cells with stromal smooth muscle cell atrophy in the mice lacking prostate epithelial androgen receptor. Plos One. 6: e20202. PMID 21754978 DOI: 10.1371/Journal.Pone.0020202 |
0.757 |
|
| 2011 |
Weng HC, Hung CM, Liu YT, Cheng YJ, Yen CY, Chang CC, Huang CK. Associations between emotional intelligence and doctor burnout, job satisfaction and patient satisfaction. Medical Education. 45: 835-42. PMID 21752080 DOI: 10.1111/j.1365-2923.2011.03985.x |
0.564 |
|
| 2011 |
Tsai MY, Shyr CR, Kang HY, Chang YC, Weng PL, Wang SY, Huang KE, Chang C. The reduced trabecular bone mass of adult ARKO male mice results from the decreased osteogenic differentiation of bone marrow stroma cells. Biochemical and Biophysical Research Communications. 411: 477-82. PMID 21723262 DOI: 10.1016/J.Bbrc.2011.06.113 |
0.678 |
|
| 2011 |
Lin YY, Chang CH, Li JJ, Stabin MG, Chang YJ, Chen LC, Lin MH, Tseng YL, Lin WJ, Lee TW, Ting G, Chang CA, Chen FD, Wang HE. Pharmacokinetics and dosimetry of (111)In/(188)Re-labeled PEGylated liposomal drugs in two colon carcinoma-bearing mouse models. Cancer Biotherapy & Radiopharmaceuticals. 26: 373-80. PMID 21711113 DOI: 10.1089/Cbr.2010.0906 |
0.618 |
|
| 2011 |
Ho CL, Liu IH, Wu YH, Chen LC, Chen CL, Lee WC, Chuang CH, Lee TW, Lin WJ, Shen LH, Chang CH. Molecular imaging, pharmacokinetics, and dosimetry of In-AMBA in human prostate tumor-bearing mice. Journal of Biomedicine & Biotechnology. 2011: 101497. PMID 21660132 DOI: 10.1155/2011/101497 |
0.64 |
|
| 2011 |
Liu SC, Peng CT, Lin TH, Wang SJ, Shih MC, Tien N, Chang CC, Lu JJ, Lin CY. Molecular lesion frequency of hemoglobin gene disorders in Taiwan. Hemoglobin. 35: 228-36. PMID 21599435 DOI: 10.3109/03630269.2011.572524 |
0.562 |
|
| 2011 |
Hsieh TH, Chen PY, Huang FL, Wang JD, Wang LC, Lin HK, Lin HC, Hsieh HY, Yu MK, Chang CF, Chuang TY, Lee CY. Are empiric antibiotics for acute exudative tonsillitis needed in children? Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi. 44: 328-32. PMID 21524968 DOI: 10.1016/j.jmii.2010.08.009 |
0.458 |
|
| 2011 |
Lee YF, Liu S, Liu NC, Wang RS, Chen LM, Lin WJ, Ting HJ, Ho HC, Li G, Puzas EJ, Wu Q, Chang C. Premature aging with impaired oxidative stress defense in mice lacking TR4. American Journal of Physiology. Endocrinology and Metabolism. 301: E91-8. PMID 21521714 DOI: 10.1152/Ajpendo.00701.2010 |
0.779 |
|
| 2011 |
Xie S, Ni J, Lee YF, Liu S, Li G, Shyr CR, Chang C. Increased acetylation in the DNA-binding domain of TR4 nuclear receptor by the coregulator ARA55 leads to suppression of TR4 transactivation. The Journal of Biological Chemistry. 286: 21129-36. PMID 21515881 DOI: 10.1074/Jbc.M110.208181 |
0.808 |
|
| 2011 |
Kim E, Liu NC, Yu IC, Lin HY, Lee YF, Sparks JD, Chen LM, Chang C. Metformin inhibits nuclear receptor TR4-mediated hepatic stearoyl-CoA desaturase 1 gene expression with altered insulin sensitivity. Diabetes. 60: 1493-503. PMID 21478464 DOI: 10.2337/Db10-0393 |
0.751 |
|
| 2011 |
Hsieh CC, Lin TH, Chang HW, Chang CW, Chang WC, Yang CC. Effect of dopants on the soft magnetic properties and high frequency characteristics of FeCoBM (M = Ti, Nb, Hf, and Ta) thin films. Journal of Nanoscience and Nanotechnology. 11: 2752-5. PMID 21449469 |
0.553 |
|
| 2011 |
Kim SJ, Choi H, Park SS, Chang C, Kim E. Stearoyl CoA desaturase (SCD) facilitates proliferation of prostate cancer cells through enhancement of androgen receptor transactivation. Molecules and Cells. 31: 371-7. PMID 21331774 DOI: 10.1007/S10059-011-0043-5 |
0.492 |
|
| 2011 |
Yu S, Zhang C, Lin CC, Niu Y, Lai KP, Chang HC, Yeh SD, Chang C, Yeh S. Altered prostate epithelial development and IGF-1 signal in mice lacking the androgen receptor in stromal smooth muscle cells. The Prostate. 71: 517-24. PMID 20945497 DOI: 10.1002/Pros.21264 |
0.766 |
|
| 2011 |
Hu YC, Chang CH, Chen CH, Ger LP, Liu WS, Lin LC, Leung CM, Chang KC. Impact of intracranial extension on survival in stage IV nasopharyngeal carcinoma: identification of a subset of patients with better prognosis. Japanese Journal of Clinical Oncology. 41: 95-102. PMID 20852300 DOI: 10.1093/jjco/hyq171 |
0.547 |
|
| 2011 |
Lu H, Yeh S, Chou Y, Tsai Y, Chang C, Wu C. Abstract 2126: Androgen receptor regulates lung cancer progress through modulation of OCT-4 expression Cancer Research. 71: 2126-2126. DOI: 10.1158/1538-7445.Am2011-2126 |
0.375 |
|
| 2011 |
Niu Y, Chang C. 1586 The Immature Differentiation Of The Prostatic Epithelial Cells In The Epithelial Specific Androgen Receptor Knockout Mouse Causes The Smooth Muscle Atrophy In Surrounding Stroma The Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.1622 |
0.433 |
|
| 2011 |
Miyamoto H, Yao J, Zheng Y, Hsu I, Izumi K, Netto G, Messing E, Chang C, Yeh S. 522 EXPRESSION OF ANDROGEN AND ESTROGEN RECEPTORS AND ITS PROGNOSTIC SIGNIFICANCE IN HIGH-GRADE UROTHELIAL CARCINOMA OF THE BLADDER Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.1218 |
0.349 |
|
| 2010 |
Okitsu K, Kanda T, Imazeki F, Yonemitsu Y, Ray RB, Chang C, Yokosuka O. Involvement of interleukin-6 and androgen receptor signaling in pancreatic cancer. Genes & Cancer. 1: 859-67. PMID 21779469 DOI: 10.1177/1947601910383417 |
0.37 |
|
| 2010 |
Liu NC, Chang CS, Chen SY, Tsai PL, Yu FL, Hsu WY. [Appending Chinese language names to medicine labels: the effect on nursing staff label recognition efficacy]. Hu Li Za Zhi the Journal of Nursing. 57: 47-56. PMID 20878610 |
0.684 |
|
| 2010 |
Chen CY, Hsu CL, Chang CH, Chen KY, Yu CJ, Yang PC. Hemothorax in a medical intensive care unit: incidence, comorbidity and prognostic factors. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 109: 574-81. PMID 20708508 DOI: 10.1016/S0929-6646(10)60094-0 |
0.524 |
|
| 2010 |
Chang CY, Huang CK, Chang YY, Tai CM, Lin JT, Wang JD. Prospective study of health-related quality of life after Roux-en-Y bypass surgery for morbid obesity. The British Journal of Surgery. 97: 1541-6. PMID 20645295 DOI: 10.1002/bjs.7179 |
0.552 |
|
| 2010 |
Tai CM, Lee YC, Tu HP, Huang CK, Wu MT, Chang CY, Lee CT, Wu MS, Lin JT, Wang WM. The relationship between visceral adiposity and the risk of erosive esophagitis in severely obese Chinese patients. Obesity (Silver Spring, Md.). 18: 2165-9. PMID 20559298 DOI: 10.1038/oby.2010.143 |
0.569 |
|
| 2010 |
Wu MH, Ma WL, Hsu CL, Chen YL, Ou JH, Ryan CK, Hung YC, Yeh S, Chang C. Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Science Translational Medicine. 2: 32ra35. PMID 20484730 DOI: 10.1126/Scitranslmed.3001143 |
0.77 |
|
| 2010 |
Niu Y, Chang TM, Yeh S, Ma WL, Wang YZ, Chang C. Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails. Oncogene. 29: 3593-604. PMID 20440270 DOI: 10.1038/Onc.2010.121 |
0.732 |
|
| 2010 |
Chen CL, Kuo LR, Chang CL, Hwu YK, Huang CK, Lee SY, Chen K, Lin SJ, Huang JD, Chen YY. In situ real-time investigation of cancer cell photothermolysis mediated by excited gold nanorod surface plasmons. Biomaterials. 31: 4104-12. PMID 20181393 DOI: 10.1016/j.biomaterials.2010.01.140 |
0.61 |
|
| 2010 |
Shyr CR, Tsai MY, Yeh S, Kang HY, Chang YC, Wong PL, Huang CC, Huang KE, Chang C. Tumor suppressor PAX6 functions as androgen receptor co-repressor to inhibit prostate cancer growth. The Prostate. 70: 190-9. PMID 19790232 DOI: 10.1002/Pros.21052 |
0.75 |
|
| 2010 |
Ma W, Hsu C, Wu M, Huang C, Hsu J, Chen C, Wu C, Chang C. Abstract 2917: Novel function of androgen receptor: Cancer suppressor in hepatocellular carcinoma Cancer Research. 70: 2917-2917. DOI: 10.1158/1538-7445.Am10-2917 |
0.784 |
|
| 2009 |
Lai JJ, Lai KP, Chuang KH, Chang P, Yu IC, Lin WJ, Chang C. Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression. The Journal of Clinical Investigation. 119: 3739-51. PMID 19907077 DOI: 10.1172/Jci39335 |
0.805 |
|
| 2009 |
Zeng WP, Chang C, Lai JJ. Immune suppressive activity and lack of T helper differentiation are differentially regulated in natural regulatory T cells. Journal of Immunology (Baltimore, Md. : 1950). 183: 3583-90. PMID 19710452 DOI: 10.4049/Jimmunol.0900146 |
0.762 |
|
| 2009 |
Lin YY, Li JJ, Chang CH, Lu YC, Hwang JJ, Tseng YL, Lin WJ, Ting G, Wang HE. Evaluation of pharmacokinetics of 111In-labeled VNB-PEGylated liposomes after intraperitoneal and intravenous administration in a tumor/ascites mouse model. Cancer Biotherapy & Radiopharmaceuticals. 24: 453-60. PMID 19694580 DOI: 10.1089/cbr.2008.0572 |
0.611 |
|
| 2009 |
Ho CL, Chen LC, Lee WC, Chiu SP, Hsu WC, Wu YH, Yeh CH, Stabin MG, Jan ML, Lin WJ, Lee TW, Chang CH. Receptor-binding, biodistribution, dosimetry, and micro-SPECT/CT imaging of 111In-[DTPA(1), Lys(3), Tyr(4)]-bombesin analog in human prostate tumor-bearing mice. Cancer Biotherapy & Radiopharmaceuticals. 24: 435-43. PMID 19694578 DOI: 10.1089/Cbr.2008.0616 |
0.66 |
|
| 2009 |
Xie S, Lee YF, Kim E, Chen LM, Ni J, Fang LY, Liu S, Lin SJ, Abe J, Berk B, Ho FM, Chang C. TR4 nuclear receptor functions as a fatty acid sensor to modulate CD36 expression and foam cell formation. Proceedings of the National Academy of Sciences of the United States of America. 106: 13353-8. PMID 19666541 DOI: 10.1073/Pnas.0905724106 |
0.795 |
|
| 2009 |
Zhang L, Altuwaijri S, Deng F, Chen L, Lal P, Bhanot UK, Korets R, Wenske S, Lilja HG, Chang C, Scher HI, Gerald WL. NF-κB regulates androgen receptor expression and prostate cancer growth American Journal of Pathology. 175: 489-499. PMID 19628766 DOI: 10.2353/Ajpath.2009.080727 |
0.727 |
|
| 2009 |
Chen BY, Yen CY, Chen WM, Chang CT, Wang CT, Hu YC. Exploring threshold operation criteria of biostimulation for azo dye decolorization using immobilized cell systems. Bioresource Technology. 100: 5763-70. PMID 19628386 DOI: 10.1016/j.biortech.2009.06.080 |
0.553 |
|
| 2009 |
Liu NC, Lin WJ, Yu IC, Lin HY, Liu S, Lee YF, Chang C. Activation of TR4 orphan nuclear receptor gene promoter by cAMP/PKA and C/EBP signaling. Endocrine. 36: 211-7. PMID 19618297 DOI: 10.1007/S12020-009-9220-0 |
0.797 |
|
| 2009 |
Chuang KH, Altuwaijri S, Li G, Lai JJ, Chu CY, Lai KP, Lin HY, Hsu JW, Keng P, Wu MC, Chang C. Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor. The Journal of Experimental Medicine. 206: 1181-99. PMID 19414555 DOI: 10.1084/Jem.20082521 |
0.802 |
|
| 2009 |
Chang TJ, Chang YJ, Ho TY, Hsiang CY, Yu CY, Lee TW, Lin WJ, Chang CH. Noninvasive bioluminescent and microPET imaging for the regulation of NF-kappaB in human hepatoma-bearing mice. Anticancer Research. 29: 987-94. PMID 19414336 |
0.619 |
|
| 2009 |
Liu RS, Chou TK, Chang CH, Wu CY, Chang CW, Chang TJ, Wang SJ, Lin WJ, Wang HE. Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model. Nuclear Medicine and Biology. 36: 305-12. PMID 19324276 DOI: 10.1016/j.nucmedbio.2008.12.011 |
0.583 |
|
| 2009 |
Chang CW, Lin YY, Peng CJ, Lin M, Liu RS, Wang SJ, Lin WJ, Wang HE. The robotic radiosynthesis of 5-[(18)F]fluoro-2'-deoxyuridine and its biological characterization. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 67: 1355-61. PMID 19307130 DOI: 10.1016/j.apradiso.2009.02.079 |
0.595 |
|
| 2009 |
Kang HY, Huang HY, Hsieh CY, Li CF, Shyr CR, Tsai MY, Chang C, Chuang YC, Huang KE. Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancer. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 24: 1180-93. PMID 19257827 DOI: 10.1359/Jbmr.090219 |
0.741 |
|
| 2009 |
Hsu CL, Chang CH, Wong KN, Chen KY, Yu CJ, Yang PC. Management of severe community-acquired septic meningitis in adults: from emergency department to intensive care unit. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 108: 112-8. PMID 19251546 DOI: 10.1016/S0929-6646(09)60041-3 |
0.523 |
|
| 2009 |
Wang RS, Yeh S, Tzeng CR, Chang C. Androgen receptor roles in spermatogenesis and fertility: lessons from testicular cell-specific androgen receptor knockout mice. Endocrine Reviews. 30: 119-32. PMID 19176467 DOI: 10.1210/Er.2008-0025 |
0.458 |
|
| 2009 |
Altuwaijri S, Chuang KH, Lai KP, Lai JJ, Lin HY, Young FM, Bottaro A, Tsai MY, Zeng WP, Chang HC, Yeh S, Chang C. Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells. Molecular Endocrinology (Baltimore, Md.). 23: 444-53. PMID 19164450 DOI: 10.1210/Jcem.94.3.9999 |
0.815 |
|
| 2009 |
Shyr CR, Kang HY, Tsai MY, Liu NC, Ku PY, Huang KE, Chang C. Roles of testicular orphan nuclear receptors 2 and 4 in early embryonic development and embryonic stem cells. Endocrinology. 150: 2454-62. PMID 19131575 DOI: 10.1210/En.2008-1165 |
0.811 |
|
| 2009 |
Yu SQ, Lai KP, Xia SJ, Chang HC, Chang C, Yeh S. The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer. Asian Journal of Andrology. 11: 39-48. PMID 19098932 DOI: 10.1038/Aja.2008.44 |
0.768 |
|
| 2009 |
Chen M, Wolfe A, Wang X, Chang C, Yeh S, Radovick S. Generation and characterization of a complete null estrogen receptor alpha mouse using Cre/LoxP technology. Molecular and Cellular Biochemistry. 321: 145-53. PMID 18953638 DOI: 10.1007/S11010-008-9928-9 |
0.358 |
|
| 2009 |
Chen M, Hsu I, Wolfe A, Radovick S, Huang K, Yu S, Chang C, Messing EM, Yeh S. Defects of prostate development and reproductive system in the estrogen receptor-alpha null male mice. Endocrinology. 150: 251-9. PMID 18755802 DOI: 10.1210/En.2008-0044 |
0.43 |
|
| 2009 |
Chang C. IL1 Dual Roles of Androgen Receptor Challenge the Androgen Deprivation Therapy of Prostate Cancer(The 97th Annual Meeting of the Japanese Urological Association) The Japanese Journal of Urology. 100: 40. DOI: 10.5980/Jpnjurol.100.40 |
0.398 |
|
| 2009 |
Niu Y, Yeh S, Chang C. LOSS OF EPITHELIAL ANDROGEN RECEPTOR PROMOTES PROSTATE CANCER PROGRESSION Journal of Urology. 181: 260-260. DOI: 10.1016/S0022-5347(09)60740-0 |
0.45 |
|
| 2008 |
Chang CC, Yeh MS, Lin HK, Cheng W. The effect of Vibrio alginolyticus infection on caspase-3 expression and activity in white shrimp Litopenaeus vannamei. Fish & Shellfish Immunology. 25: 672-8. PMID 18840531 DOI: 10.1016/j.fsi.2008.09.004 |
0.496 |
|
| 2008 |
Kang HY, Shyr CR, Huang CK, Tsai MY, Orimo H, Lin PC, Chang C, Huang KE. Altered TNSALP expression and phosphate regulation contribute to reduced mineralization in mice lacking androgen receptor. Molecular and Cellular Biology. 28: 7354-67. PMID 18838539 DOI: 10.1128/Mcb.00582-08 |
0.801 |
|
| 2008 |
Niu Y, Yeh S, Miyamoto H, Li G, Altuwaijri S, Yuan J, Han R, Ma T, Kuo HC, Chang C. Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation. Cancer Research. 68: 7110-9. PMID 18757426 DOI: 10.1158/0008-5472.Can-07-6507 |
0.729 |
|
| 2008 |
Niu Y, Altuwaijri S, Lai KP, Wu CT, Ricke WA, Messing EM, Yao J, Yeh S, Chang C. Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 105: 12182-7. PMID 18723679 DOI: 10.1073/Pnas.0804700105 |
0.841 |
|
| 2008 |
Niu Y, Altuwaijri S, Yeh S, Lai KP, Yu S, Chuang KH, Huang SP, Lardy H, Chang C. Targeting the stromal androgen receptor in primary prostate tumors at earlier stages Proceedings of the National Academy of Sciences of the United States of America. 105: 12188-12193. PMID 18723670 DOI: 10.1073/Pnas.0804701105 |
0.828 |
|
| 2008 |
Ma WL, Ma CL, Hsu CL, Wu MH, Wu CT, Wu CC, Lai JJ, Jou YS, Chen CW, Yeh S, Chang C. Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma. Gastroenterology. 135: 947-55, 955.e1-5. PMID 18639551 DOI: 10.1053/J.Gastro.2008.05.046 |
0.801 |
|
| 2008 |
Ting HJ, Chang C. Actin associated proteins function as androgen receptor coregulators: an implication of androgen receptor's roles in skeletal muscle. The Journal of Steroid Biochemistry and Molecular Biology. 111: 157-63. PMID 18590822 DOI: 10.1016/J.Jsbmb.2008.06.001 |
0.7 |
|
| 2008 |
Lin HY, Yu IC, Wang RS, Chen YT, Liu NC, Altuwaijri S, Hsu CL, Ma WL, Jokinen J, Sparks JD, Yeh S, Chang C. Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology (Baltimore, Md.). 47: 1924-35. PMID 18449947 DOI: 10.1002/Hep.22252 |
0.801 |
|
| 2008 |
Chen YT, Collins LL, Chang SS, Chang C. The roles of testicular orphan nuclear receptor 4 (TR4) in cerebellar development. Cerebellum (London, England). 7: 9-17. PMID 18418664 DOI: 10.1007/S12311-008-0006-3 |
0.666 |
|
| 2008 |
Li G, Lee YF, Liu S, Cai Y, Xie S, Liu NC, Bao BY, Chen Z, Chang C. Oxidative stress stimulates testicular orphan receptor 4 through forkhead transcription factor forkhead box O3a. Endocrinology. 149: 3490-9. PMID 18388194 DOI: 10.1210/En.2008-0121 |
0.786 |
|
| 2008 |
Cai Y, Lee YF, Li G, Liu S, Bao BY, Huang J, Hsu CL, Chang C. A new prostate cancer therapeutic approach: combination of androgen ablation with COX-2 inhibitor. International Journal of Cancer. 123: 195-201. PMID 18386814 DOI: 10.1002/Ijc.23481 |
0.698 |
|
| 2008 |
Yu IC, Lin HY, Liu NC, Wang RS, Sparks JD, Yeh S, Chang C. Hyperleptinemia without obesity in male mice lacking androgen receptor in adipose tissue. Endocrinology. 149: 2361-8. PMID 18276764 DOI: 10.1210/En.2007-0516 |
0.769 |
|
| 2008 |
Chen LM, Wang RS, Lee YF, Liu NC, Chang YJ, Wu CC, Xie S, Hung YC, Chang C. Subfertility with defective folliculogenesis in female mice lacking testicular orphan nuclear receptor 4. Molecular Endocrinology (Baltimore, Md.). 22: 858-67. PMID 18174360 DOI: 10.1210/Me.2007-0181 |
0.804 |
|
| 2008 |
Niu Y, Han R, Yeh S, Messing EM, Chang C. THE PROSTATIC EPITHELIAL SPECIFIC ANDROGEN RECEPTOR KNOCKOUT TRAMP MICE: AN ANIMAL MODEL FOR ANDROGEN INDEPENDENT PROSTATIC TUMOR Journal of Urology. 179: 188-188. DOI: 10.1016/S0022-5347(08)60546-7 |
0.43 |
|
| 2007 |
Xu Q, Lin HY, Yeh SD, Yu IC, Wang RS, Chen YT, Zhang C, Altuwaijri S, Chen LM, Chuang KH, Chiang HS, Yeh S, Chang C. Infertility with defective spermatogenesis and steroidogenesis in male mice lacking androgen receptor in Leydig cells. Endocrine. 32: 96-106. PMID 17955388 DOI: 10.1007/S12020-007-9015-0 |
0.822 |
|
| 2007 |
Lee CC, Lin WJ, Shih HI, Wu CJ, Chen PL, Lee HC, Lee NY, Chang CM, Wang LR, Ko WC. Clinical significance of potential contaminants in blood cultures among patients in a medical center. Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi. 40: 438-44. PMID 17932605 |
0.587 |
|
| 2007 |
Liu NC, Lin WJ, Kim E, Collins LL, Lin HY, Yu IC, Sparks JD, Chen LM, Lee YF, Chang C. Loss of TR4 orphan nuclear receptor reduces phosphoenolpyruvate carboxykinase-mediated gluconeogenesis. Diabetes. 56: 2901-9. PMID 17827404 DOI: 10.2337/Db07-0359 |
0.794 |
|
| 2007 |
Chen YT, Collins LL, Uno H, Chou SM, Meshul CK, Chang SS, Chang C. Abnormal cerebellar cytoarchitecture and impaired inhibitory signaling in adult mice lacking TR4 orphan nuclear receptor. Brain Research. 1168: 72-82. PMID 17706948 DOI: 10.1016/J.Brainres.2007.06.069 |
0.665 |
|
| 2007 |
Kim E, Ma WL, Lin DL, Inui S, Chen YL, Chang C. TR4 orphan nuclear receptor functions as an apoptosis modulator via regulation of Bcl-2 gene expression. Biochemical and Biophysical Research Communications. 361: 323-8. PMID 17655826 DOI: 10.1016/J.Bbrc.2007.06.168 |
0.7 |
|
| 2007 |
Wu CT, Altuwaijri S, Ricke WA, Huang SP, Yeh S, Zhang C, Niu Y, Tsai MY, Chang C. Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor. Proceedings of the National Academy of Sciences of the United States of America. 104: 12679-84. PMID 17652515 DOI: 10.1073/Pnas.0704940104 |
0.729 |
|
| 2007 |
Yeh CC, Lin TH, Wu HC, Chang CH, Chen CC, Chen WC. A high association of upper urinary tract transitional cell carcinoma with nonfunctioning kidney caused by stone disease in Taiwan. Urologia Internationalis. 79: 19-23. PMID 17627162 DOI: 10.1159/000102907 |
0.585 |
|
| 2007 |
Chen CH, Chang CM, Chen HY, Lai JJ, Sun CM. Scaffold-directed traceless synthesis of tetrahydro-beta-carbolinehydantoins. Journal of Combinatorial Chemistry. 9: 618-26. PMID 17583962 DOI: 10.1021/cc070035w |
0.71 |
|
| 2007 |
Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Yeh S, Messing EM, Chang C. Promotion of bladder cancer development and progression by androgen receptor signals. Journal of the National Cancer Institute. 99: 558-68. PMID 17406000 DOI: 10.1093/Jnci/Djk113 |
0.793 |
|
| 2007 |
Chang CW, Chou TK, Liu RS, Wang SJ, Lin WJ, Chen CH, Wang HE. A robotic synthesis of [18F]fluoromisonidazole ([18F]FMISO). Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 65: 682-6. PMID 17379530 DOI: 10.1016/j.apradiso.2007.01.005 |
0.583 |
|
| 2007 |
Shi W, Chang C, Nie S, Xie S, Wan M, Cao X. Endofin acts as a Smad anchor for receptor activation in BMP signaling. Journal of Cell Science. 120: 1216-24. PMID 17356069 DOI: 10.1242/Jcs.03400 |
0.709 |
|
| 2007 |
Zheng Y, Chen WL, Ma WL, Chang C, Ou JH. Enhancement of gene transactivation activity of androgen receptor by hepatitis B virus X protein. Virology. 363: 454-61. PMID 17335866 DOI: 10.1016/J.Virol.2007.01.040 |
0.703 |
|
| 2007 |
Altuwaijri S, Wu CC, Niu YJ, Mizokami A, Chang HC, Chang C. Expression of human AR cDNA driven by its own promoter results in mild promotion, but not suppression, of growth in human prostate cancer PC-3 cells. Asian Journal of Andrology. 9: 181-8. PMID 17334587 DOI: 10.1111/J.1745-7262.2007.00258.X |
0.728 |
|
| 2007 |
Yang Z, Chang YJ, Yu IC, Yeh S, Wu CC, Miyamoto H, Merry DE, Sobue G, Chen LM, Chang SS, Chang C. ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nature Medicine. 13: 348-53. PMID 17334372 DOI: 10.1038/Nm1547 |
0.399 |
|
| 2007 |
Juang SH, Lung CC, Hsu PC, Hsu KS, Li YC, Hong PC, Shiah HS, Kuo CC, Huang CW, Wang YC, Huang L, Chen TS, Chen SF, Fu KC, Hsu CL, ... ... Chang CJ, et al. D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation. Molecular Cancer Therapeutics. 6: 193-202. PMID 17237279 DOI: 10.1158/1535-7163.MCT-06-0482 |
0.579 |
|
| 2007 |
Zhang Y, Chen YT, Xie S, Wang L, Lee YF, Chang SS, Chang C. Loss of testicular orphan receptor 4 impairs normal myelination in mouse forebrain. Molecular Endocrinology (Baltimore, Md.). 21: 908-20. PMID 17227886 DOI: 10.1210/Me.2006-0219 |
0.794 |
|
| 2007 |
Yang Z, Chang YJ, Miyamoto H, Yeh S, Yao JL, di Sant'Agnese PA, Tsai MY, Chang C. Suppression of androgen receptor transactivation and prostate cancer cell growth by heterogeneous nuclear ribonucleoprotein A1 via interaction with androgen receptor coregulator ARA54. Endocrinology. 148: 1340-9. PMID 17110431 DOI: 10.1210/En.2006-0716 |
0.45 |
|
| 2007 |
Yang Z, Chang YJ, Miyamoto H, Ni J, Niu Y, Chen Z, Chen YL, Yao JL, di Sant'Agnese PA, Chang C. Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth. Molecular Endocrinology (Baltimore, Md.). 21: 343-58. PMID 17082327 DOI: 10.1210/Me.2006-0104 |
0.484 |
|
| 2007 |
Niu Y, Chang C, Han R, Ma T. 266: Prostate-Specific Antigen Promote Prostate Cancer Cell Growth Via Modulating Androgen Receptor Activation Journal of Urology. 177: 89-89. DOI: 10.1016/S0022-5347(18)30531-7 |
0.434 |
|
| 2006 |
Tsai MY, Yeh SD, Wang RS, Yeh S, Zhang C, Lin HY, Tzeng CR, Chang C. Differential effects of spermatogenesis and fertility in mice lacking androgen receptor in individual testis cells. Proceedings of the National Academy of Sciences of the United States of America. 103: 18975-80. PMID 17142319 DOI: 10.1073/Pnas.0608565103 |
0.415 |
|
| 2006 |
Zhang C, Yeh S, Chen YT, Wu CC, Chuang KH, Lin HY, Wang RS, Chang YJ, Mendis-Handagama C, Hu L, Lardy H, Chang C. Oligozoospermia with normal fertility in male mice lacking the androgen receptor in testis peritubular myoid cells Proceedings of the National Academy of Sciences of the United States of America. 103: 17718-17723. PMID 17095600 DOI: 10.1073/Pnas.0608556103 |
0.783 |
|
| 2006 |
Wang CP, Lee YF, Chang C, Lee HJ. Transactivation of the proximal promoter of human oxytocin gene by TR4 orphan receptor. Biochemical and Biophysical Research Communications. 351: 204-8. PMID 17054912 DOI: 10.1016/J.Bbrc.2006.10.021 |
0.32 |
|
| 2006 |
Wang RS, Yeh S, Chen LM, Lin HY, Zhang C, Ni J, Wu CC, di Sant'Agnese PA, deMesy-Bentley KL, Tzeng CR, Chang C. Androgen receptor in sertoli cell is essential for germ cell nursery and junctional complex formation in mouse testes. Endocrinology. 147: 5624-33. PMID 16973730 DOI: 10.1210/En.2006-0138 |
0.34 |
|
| 2006 |
Marwah P, Marwah A, Lardy HA, Miyamoto H, Chang C. C19-steroids as androgen receptor modulators: design, discovery, and structure-activity relationship of new steroidal androgen receptor antagonists. Bioorganic & Medicinal Chemistry. 14: 5933-47. PMID 16759873 DOI: 10.1016/J.Bmc.2006.05.022 |
0.457 |
|
| 2006 |
Leung MK, Chang CC, Wu MH, Chuang KH, Lee JH, Shieh SJ, Lin SC, Chiu CF. 6-N,N-diphenylaminobenzofuran-derived pyran containing fluorescent dyes: a new class of high-brightness red-light-emitting dopants for OLED. Organic Letters. 8: 2623-6. PMID 16737329 DOI: 10.1021/ol060803c |
0.668 |
|
| 2006 |
Chang CY, Hsuuw YD, Huang FJ, Shyr CR, Chang SY, Huang CK, Kang HY, Huang KE. Androgenic and antiandrogenic effects and expression of androgen receptor in mouse embryonic stem cells. Fertility and Sterility. 85: 1195-203. PMID 16616092 DOI: 10.1016/J.Fertnstert.2005.11.031 |
0.8 |
|
| 2006 |
Mu X, Yang L, Chang C. Stage dependent and androgen inductive expression of orphan receptor TR4 in rat testis. Biochemical and Biophysical Research Communications. 341: 464-9. PMID 16414012 DOI: 10.1016/J.Bbrc.2005.12.207 |
0.355 |
|
| 2005 |
Miyamoto H, Messing EM, Chang C. Does androgen deprivation improve treatment outcomes in patients with low-risk and intermediate-risk prostate cancer? Nature Clinical Practice. Oncology. 2: 236-7. PMID 16264955 DOI: 10.1038/Ncponc0168 |
0.332 |
|
| 2005 |
Yang L, Xie S, Jamaluddin MS, Altuwaijri S, Ni J, Kim E, Chen YT, Hu YC, Wang L, Chuang KH, Wu CT, Chang C. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells. The Journal of Biological Chemistry. 280: 33558-65. PMID 16061480 DOI: 10.1074/Jbc.M504461200 |
0.831 |
|
| 2005 |
Miyamoto H, Altuwaijri S, Cai Y, Messing EM, Chang C. Inhibition of the Akt, cyclooxygenase-2, and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: potential therapeutic approaches for prostate cancer. Molecular Carcinogenesis. 44: 1-10. PMID 16044418 DOI: 10.1002/Mc.20121 |
0.725 |
|
| 2005 |
Miyamoto H, Marwah P, Marwah A, Yang Z, Chung CY, Altuwaijri S, Chang C, Lardy H. Identification of steroid derivatives that function as potent antiandrogens International Journal of Cancer. 117: 866-872. PMID 15981214 DOI: 10.1002/Ijc.21217 |
0.733 |
|
| 2005 |
Su JL, Lai KP, Chen CA, Yang CY, Chen PS, Chang CC, Chou CH, Hu CL, Kuo ML, Hsieh CY, Wei LH. A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth. Cancer Research. 65: 4827-35. PMID 15930303 DOI: 10.1158/0008-5472.CAN-05-0188 |
0.666 |
|
| 2005 |
Fujimoto N, Chang C, Nomura M, Matsumoto T. Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention. Urologia Internationalis. 74: 289-97. PMID 15897691 DOI: 10.1159/000084425 |
0.381 |
|
| 2005 |
Chen YT, Collins LL, Uno H, Chang C. Deficits in motor coordination with aberrant cerebellar development in mice lacking testicular orphan nuclear receptor 4. Molecular and Cellular Biology. 25: 2722-32. PMID 15767677 DOI: 10.1128/Mcb.25.7.2722-2732.2005 |
0.665 |
|
| 2005 |
Hsu CL, Chen KY, Chang CH, Jerng JS, Yu CJ, Yang PC. Timing of tracheostomy as a determinant of weaning success in critically ill patients: a retrospective study. Critical Care (London, England). 9: R46-52. PMID 15693966 DOI: 10.1186/cc3018 |
0.536 |
|
| 2005 |
Kim E, Yang Z, Liu NC, Chang C. Induction of apolipoprotein E expression by TR4 orphan nuclear receptor via 5' proximal promoter region. Biochemical and Biophysical Research Communications. 328: 85-90. PMID 15670754 DOI: 10.1016/J.Bbrc.2004.12.146 |
0.752 |
|
| 2005 |
Chuang KH, Lee YF, Lin WJ, Chu CY, Altuwaijri S, Wan YJ, Chang C. 9-cis-retinoic acid inhibits androgen receptor activity through activation of retinoid X receptor. Molecular Endocrinology (Baltimore, Md.). 19: 1200-12. PMID 15650026 DOI: 10.1210/Me.2004-0181 |
0.816 |
|
| 2005 |
Hsu CL, Chen YL, Ting HJ, Lin WJ, Yang Z, Zhang Y, Wang L, Wu CT, Chang HC, Yeh S, Pimplikar SW, Chang C. Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth. Molecular Endocrinology (Baltimore, Md.). 19: 350-61. PMID 15514032 DOI: 10.1210/Me.2004-0190 |
0.818 |
|
| 2005 |
Wang L, Hsu CL, Chang C. Androgen receptor corepressors: an overview. The Prostate. 63: 117-30. PMID 15486994 DOI: 10.1002/Pros.20170 |
0.7 |
|
| 2005 |
Miyamoto H, Yang Z, Chang C. 590: Mice Deficient in Androgen Receptor are Resistant to Bladder Carcinogenesis Journal of Urology. 173: 161-161. DOI: 10.1016/S0022-5347(18)34830-4 |
0.371 |
|
| 2004 |
Altuwaijri S, Lee DK, Chuang KH, Ting HJ, Yang Z, Xu Q, Tsai MY, Yeh S, Hanchett LA, Chang HC, Chang C. Androgen receptor regulates expression of skeletal muscle-specific proteins and muscle cell types. Endocrine. 25: 27-32. PMID 15545703 DOI: 10.1385/Endo:25:1:27 |
0.794 |
|
| 2004 |
Collins LL, Lee YF, Heinlein CA, Liu NC, Chen YT, Shyr CR, Meshul CK, Uno H, Platt KA, Chang C. Growth retardation and abnormal maternal behavior in mice lacking testicular orphan nuclear receptor 4. Proceedings of the National Academy of Sciences of the United States of America. 101: 15058-63. PMID 15477591 DOI: 10.1073/Pnas.0405700101 |
0.804 |
|
| 2004 |
Miyamoto H, Messing EM, Chang C. Androgen deprivation therapy for prostate cancer: current status and future prospects. The Prostate. 61: 332-53. PMID 15389811 DOI: 10.1002/Pros.20115 |
0.416 |
|
| 2004 |
Lee YF, Bao BY, Chang C. Modulation of the retinoic acid-induced cell apoptosis and differentiation by the human TR4 orphan nuclear receptor. Biochemical and Biophysical Research Communications. 323: 876-83. PMID 15381082 DOI: 10.1016/J.Bbrc.2004.08.176 |
0.356 |
|
| 2004 |
Hu YC, Wang PH, Yeh S, Wang RS, Xie C, Xu Q, Zhou X, Chao HT, Tsai MY, Chang C. Subfertility and defective folliculogenesis in female mice lacking androgen receptor. Proceedings of the National Academy of Sciences of the United States of America. 101: 11209-14. PMID 15277682 DOI: 10.1073/Pnas.0404372101 |
0.685 |
|
| 2004 |
Lin HK, Hu YC, Lee DK, Chang C. Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells. Molecular Endocrinology (Baltimore, Md.). 18: 2409-23. PMID 15205473 DOI: 10.1210/Me.2004-0117 |
0.796 |
|
| 2004 |
Mu X, Lee YF, Liu NC, Chen YT, Kim E, Shyr CR, Chang C. Targeted inactivation of testicular nuclear orphan receptor 4 delays and disrupts late meiotic prophase and subsequent meiotic divisions of spermatogenesis. Molecular and Cellular Biology. 24: 5887-99. PMID 15199144 DOI: 10.1128/Mcb.24.13.5887-5899.2004 |
0.791 |
|
| 2004 |
Wang L, Lin HK, Hu YC, Xie S, Yang L, Chang C. Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells. The Journal of Biological Chemistry. 279: 32444-52. PMID 15178691 DOI: 10.1074/Jbc.M313963200 |
0.811 |
|
| 2004 |
Ting HJ, Hu YC, Chang C. Actin monomer enhances supervillin-modulated androgen receptor transactivation. Biochemical and Biophysical Research Communications. 319: 393-6. PMID 15178419 DOI: 10.1016/J.Bbrc.2004.04.186 |
0.789 |
|
| 2004 |
Kang HY, Cho CL, Huang KL, Wang JC, Hu YC, Lin HK, Chang C, Huang KE. Nongenomic androgen activation of phosphatidylinositol 3-kinase/Akt signaling pathway in MC3T3-E1 osteoblasts. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 19: 1181-90. PMID 15177002 DOI: 10.1359/Jbmr.040306 |
0.765 |
|
| 2004 |
Hu YC, Yeh S, Yeh SD, Sampson ER, Huang J, Li P, Hsu CL, Ting HJ, Lin HK, Wang L, Kim E, Ni J, Chang C. Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. The Journal of Biological Chemistry. 279: 33438-46. PMID 15166229 DOI: 10.1074/Jbc.M401781200 |
0.834 |
|
| 2004 |
Xie S, Lin HK, Ni J, Yang L, Wang L, di Sant'Agnese PA, Chang C. Regulation of interleukin-6-mediated PI3K activation and neuroendocrine differentiation by androgen signaling in prostate cancer LNCaP cells. The Prostate. 60: 61-7. PMID 15129430 DOI: 10.1002/Pros.20048 |
0.806 |
|
| 2004 |
Chang C, Chen YT, Yeh SD, Xu Q, Wang RS, Guillou F, Lardy H, Yeh S. Infertility with defective spermatogenesis and hypotestosteronemia in male mice lacking the androgen receptor in Sertoli cells. Proceedings of the National Academy of Sciences of the United States of America. 101: 6876-81. PMID 15107499 DOI: 10.1073/Pnas.0307306101 |
0.432 |
|
| 2004 |
Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocrine Reviews. 25: 276-308. PMID 15082523 DOI: 10.1210/Er.2002-0032 |
0.463 |
|
| 2004 |
Rahman M, Miyamoto H, Chang C. Androgen receptor coregulators in prostate cancer: mechanisms and clinical implications. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 2208-19. PMID 15073094 DOI: 10.1158/1078-0432.Ccr-0746-3 |
0.673 |
|
| 2004 |
Litvinov IV, Chang C, Isaacs JT. Molecular characterization of the commonly used human androgen receptor expression vector, pSG5-AR. The Prostate. 58: 319-24. PMID 14968432 DOI: 10.1002/Pros.20027 |
0.396 |
|
| 2004 |
Wang L, Hsu CL, Ni J, Wang PH, Yeh S, Keng P, Chang C. Human checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cells. Molecular and Cellular Biology. 24: 2202-13. PMID 14966297 DOI: 10.1128/Mcb.24.5.2202-2213.2004 |
0.716 |
|
| 2004 |
Zhang Y, Yang Y, Yeh S, Chang C. ARA67/PAT1 functions as a repressor to suppress androgen receptor transactivation. Molecular and Cellular Biology. 24: 1044-57. PMID 14729952 DOI: 10.1128/Mcb.24.12.5635.2004 |
0.463 |
|
| 2004 |
Yang L, Yeh SD, Xie S, Altuwaijri S, Ni J, Hu YC, Chen YT, Bao BY, Su CH, Chang C. Androgen suppresses PML protein expression in prostate cancer CWR22R cells. Biochemical and Biophysical Research Communications. 314: 69-75. PMID 14715247 DOI: 10.1016/J.Bbrc.2003.12.060 |
0.832 |
|
| 2004 |
Miyamoto H, Rahman MM, Chang C. Molecular basis for the antiandrogen withdrawal syndrome. Journal of Cellular Biochemistry. 91: 3-12. PMID 14689576 DOI: 10.1002/Jcb.10757 |
0.63 |
|
| 2004 |
Nishimura K, Oka D, Shimizu K, Shiba M, Arai Y, Nakayama M, Inoue H, Takaha N, Nonomura N, Chang C, Ting H, Okuyama A. 586: A Novel Function of Gelsolin as a Coregulator of Androgen Receptor Journal of Urology. 171: 155-156. DOI: 10.1016/S0022-5347(18)37848-0 |
0.72 |
|
| 2003 |
Yeh S, Hu YC, Wang PH, Xie C, Xu Q, Tsai MY, Dong Z, Wang RS, Lee TH, Chang C. Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor. The Journal of Experimental Medicine. 198: 1899-908. PMID 14676301 DOI: 10.1084/Jem.20031233 |
0.694 |
|
| 2003 |
Altuwaijri S, Lin HK, Chuang KH, Lin WJ, Yeh S, Hanchett LA, Rahman MM, Kang HY, Tsai MY, Zhang Y, Yang L, Chang C. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells. Cancer Research. 63: 7106-12. PMID 14612503 |
0.823 |
|
| 2003 |
Fu M, Rao M, Wang C, Sakamaki T, Wang J, Di Vizio D, Zhang X, Albanese C, Balk S, Chang C, Fan S, Rosen E, Palvimo JJ, Jänne OA, Muratoglu S, et al. Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth. Molecular and Cellular Biology. 23: 8563-75. PMID 14612401 DOI: 10.1128/Mcb.23.23.8563-8575.2003 |
0.412 |
|
| 2003 |
Ohtsu H, Itokawa H, Xiao Z, Su CY, Shih CC, Chiang T, Chang E, Lee Y, Chiu SY, Chang C, Lee KH. Antitumor agents 222. Synthesis and anti-androgen activity of new diarylheptanoids. Bioorganic & Medicinal Chemistry. 11: 5083-90. PMID 14604672 DOI: 10.1016/J.Bmc.2003.08.029 |
0.426 |
|
| 2003 |
Lin HK, Hu YC, Yang L, Altuwaijri S, Chen YT, Kang HY, Chang C. Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers. The Journal of Biological Chemistry. 278: 50902-7. PMID 14555644 DOI: 10.1074/Jbc.M300676200 |
0.833 |
|
| 2003 |
Lee HJ, Chang C. Recent advances in androgen receptor action. Cellular and Molecular Life Sciences : Cmls. 60: 1613-22. PMID 14504652 DOI: 10.1007/S00018-003-2309-3 |
0.426 |
|
| 2003 |
Lee DK, Chang C. Endocrine mechanisms of disease: Expression and degradation of androgen receptor: mechanism and clinical implication. The Journal of Clinical Endocrinology and Metabolism. 88: 4043-54. PMID 12970260 DOI: 10.1210/Jc.2003-030261 |
0.461 |
|
| 2003 |
Kang HY, Tsai MY, Chang C, Huang KE. Mechanisms and clinical relevance of androgens and androgen receptor actions. Chang Gung Medical Journal. 26: 388-402. PMID 12956285 |
0.323 |
|
| 2003 |
Kim E, Xie S, Yeh SD, Lee YF, Collins LL, Hu YC, Shyr CR, Mu XM, Liu NC, Chen YT, Wang PH, Chang C. Disruption of TR4 orphan nuclear receptor reduces the expression of liver apolipoprotein E/C-I/C-II gene cluster. The Journal of Biological Chemistry. 278: 46919-26. PMID 12954636 DOI: 10.1074/Jbc.M304088200 |
0.79 |
|
| 2003 |
Mu X, Chang C. TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC-3. The Prostate. 57: 129-33. PMID 12949936 DOI: 10.1002/Pros.10282 |
0.47 |
|
| 2003 |
Mu X, Chang C. TR3 orphan nuclear receptor mediates apoptosis through up-regulating E2F1 in human prostate cancer LNCaP cells. The Journal of Biological Chemistry. 278: 42840-5. PMID 12947120 DOI: 10.1074/Jbc.M305594200 |
0.436 |
|
| 2003 |
Nishimura K, Ting HJ, Harada Y, Tokizane T, Nonomura N, Kang HY, Chang HC, Yeh S, Miyamoto H, Shin M, Aozasa K, Okuyama A, Chang C. Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator. Cancer Research. 63: 4888-94. PMID 12941811 |
0.739 |
|
| 2003 |
Heinlein CA, Chang C. Induction and repression of peroxisome proliferator-activated receptor alpha transcription by coregulator ARA70. Endocrine. 21: 139-46. PMID 12897377 DOI: 10.1385/Endo:21:2:139 |
0.448 |
|
| 2003 |
Yang L, Wang L, Lin HK, Kan PY, Xie S, Tsai MY, Wang PH, Chen YT, Chang C. Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells. Biochemical and Biophysical Research Communications. 305: 462-9. PMID 12763015 DOI: 10.1016/S0006-291X(03)00792-7 |
0.798 |
|
| 2003 |
Cai Y, Dai T, Ao Y, Konishi T, Chuang KH, Lue Y, Chang C, Wan YJ. Cytochrome P450 genes are differentially expressed in female and male hepatocyte retinoid X receptor alpha-deficient mice. Endocrinology. 144: 2311-8. PMID 12746291 DOI: 10.1210/En.2002-0129 |
0.753 |
|
| 2003 |
Hsu CL, Chen YL, Yeh S, Ting HJ, Hu YC, Lin H, Wang X, Chang C. The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs. The Journal of Biological Chemistry. 278: 23691-8. PMID 12714604 DOI: 10.1074/Jbc.M211908200 |
0.796 |
|
| 2003 |
Rahman MM, Miyamoto H, Lardy H, Chang C. Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells Proceedings of the National Academy of Sciences of the United States of America. 100: 5124-5129. PMID 12700349 DOI: 10.1073/Pnas.0530097100 |
0.691 |
|
| 2003 |
Miyamoto H, Marwah P, Marwah A, Lardy H, Chang C. 3 β-Acetoxyandrost-1,5-diene-17-ethylene ketal functions as a potent antiandrogen with marginal agonist activity Proceedings of the National Academy of Sciences of the United States of America. 100: 4440-4444. PMID 12672951 DOI: 10.1073/Pnas.0831001100 |
0.46 |
|
| 2003 |
Rahman MM, Miyamoto H, Takatera H, Yeh S, Altuwaijri S, Chang C. Reducing the agonist activity of antiandrogens by a dominant-negative androgen receptor coregulator ARA70 in prostate cancer cells. The Journal of Biological Chemistry. 278: 19619-26. PMID 12649293 DOI: 10.1074/Jbc.M210941200 |
0.805 |
|
| 2003 |
Lee DK, Chang C. Molecular communication between androgen receptor and general transcription machinery. The Journal of Steroid Biochemistry and Molecular Biology. 84: 41-9. PMID 12648523 DOI: 10.1016/S0960-0760(03)00005-0 |
0.383 |
|
| 2003 |
Yang L, Lin HK, Altuwaijri S, Xie S, Wang L, Chang C. APPL suppresses androgen receptor transactivation via potentiating Akt activity. The Journal of Biological Chemistry. 278: 16820-7. PMID 12621049 DOI: 10.1074/Jbc.M213163200 |
0.814 |
|
| 2003 |
Inui S, Lee YF, Chang E, Shyr CR, Chang C. Differential and bi-directional regulation between TR2/TR4 orphan nuclear receptors and a specific ligand mediated-peroxisome proliferator-activated receptor alpha in human HaCaT keratinocytes. Journal of Dermatological Science. 31: 65-71. PMID 12615366 DOI: 10.1016/S0923-1811(02)00152-4 |
0.705 |
|
| 2003 |
Lee DK, Li M, Chang C. The second largest subunit of RNA polymerase II interacts with and enhances transactivation of androgen receptor. Biochemical and Biophysical Research Communications. 302: 162-9. PMID 12593864 DOI: 10.1016/S0006-291X(03)00126-8 |
0.39 |
|
| 2003 |
Lin WJ, Li J, Lee YF, Yeh SD, Altuwaijri S, Ou JH, Chang C. Suppression of hepatitis B virus core promoter by the nuclear orphan receptor TR4. The Journal of Biological Chemistry. 278: 9353-60. PMID 12522137 DOI: 10.1074/Jbc.M205944200 |
0.779 |
|
| 2003 |
Thin TH, Wang L, Kim E, Collins LL, Basavappa R, Chang C. Isolation and characterization of androgen receptor mutant, AR(M749L), with hypersensitivity to 17-beta estradiol treatment. The Journal of Biological Chemistry. 278: 7699-708. PMID 12499384 DOI: 10.1074/Jbc.M206172200 |
0.386 |
|
| 2003 |
Yang Y, Wang X, Dong T, Kim E, Lin WJ, Chang C. Identification of a novel testicular orphan receptor-4 (TR4)-associated protein as repressor for the selective suppression of TR4-mediated transactivation. The Journal of Biological Chemistry. 278: 7709-17. PMID 12486131 DOI: 10.1074/Jbc.M207116200 |
0.704 |
|
| 2003 |
Tsai M, Yeh S, Yeh S, Xu Q, Chang C. Normal spermatogenesis and fertility in germ cell-specific genomic androgen receptor knockout mice Fertility and Sterility. 80: 277. DOI: 10.1016/S0015-0282(03)01704-7 |
0.388 |
|
| 2002 |
Lee YF, Lin WJ, Huang J, Messing EM, Chan FL, Wilding G, Chang C. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells. Cancer Research. 62: 6039-44. PMID 12414626 |
0.716 |
|
| 2002 |
Ohtsu H, Xiao Z, Ishida J, Nagai M, Wang HK, Itokawa H, Su CY, Shih C, Chiang T, Chang E, Lee Y, Tsai MY, Chang C, Lee KH. Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as anti-prostate cancer agents. Journal of Medicinal Chemistry. 45: 5037-42. PMID 12408714 DOI: 10.1021/Jm020200G |
0.42 |
|
| 2002 |
Yeh S, Tsai MY, Xu Q, Mu XM, Lardy H, Huang KE, Lin H, Yeh SD, Altuwaijri S, Zhou X, Xing L, Boyce BF, Hung MC, Zhang S, Gan L, ... Chang C, et al. Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proceedings of the National Academy of Sciences of the United States of America. 99: 13498-503. PMID 12370412 DOI: 10.1073/Pnas.212474399 |
0.672 |
|
| 2002 |
Lee YF, Lee HJ, Chang C. Recent advances in the TR2 and TR4 orphan receptors of the nuclear receptor superfamily. The Journal of Steroid Biochemistry and Molecular Biology. 81: 291-308. PMID 12361719 DOI: 10.1016/S0960-0760(02)00118-8 |
0.366 |
|
| 2002 |
Heinlein CA, Chang C. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Molecular Endocrinology (Baltimore, Md.). 16: 2181-7. PMID 12351684 DOI: 10.1210/Me.2002-0070 |
0.439 |
|
| 2002 |
Kang HY, Huang KE, Chang SY, Ma WL, Lin WJ, Chang C. Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. The Journal of Biological Chemistry. 277: 43749-56. PMID 12226080 DOI: 10.1074/Jbc.M205603200 |
0.832 |
|
| 2002 |
Lin HK, Wang L, Hu YC, Altuwaijri S, Chang C. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. The Embo Journal. 21: 4037-48. PMID 12145204 DOI: 10.1093/Emboj/Cdf406 |
0.826 |
|
| 2002 |
Lin HK, Altuwaijri S, Lin WJ, Kan PY, Collins LL, Chang C. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells. The Journal of Biological Chemistry. 277: 36570-6. PMID 12119296 DOI: 10.1074/Jbc.M204751200 |
0.841 |
|
| 2002 |
Hu YC, Shyr CR, Che W, Mu XM, Kim E, Chang C. Suppression of estrogen receptor-mediated transcription and cell growth by interaction with TR2 orphan receptor. The Journal of Biological Chemistry. 277: 33571-9. PMID 12093804 DOI: 10.1074/Jbc.M203531200 |
0.798 |
|
| 2002 |
Li MT, Richter F, Chang C, Irwin RJ, Huang H. Androgen and retinoic acid interaction in LNCaP cells, effects on cell proliferation and expression of retinoic acid receptors and epidermal growth factor receptor. Bmc Cancer. 2: 16. PMID 12069693 DOI: 10.1186/1471-2407-2-16 |
0.444 |
|
| 2002 |
Thin TH, Kim E, Yeh S, Sampson ER, Chen YT, Collins LL, Basavappa R, Chang C. Mutations in the helix 3 region of the androgen receptor abrogate ARA70 promotion of 17beta-estradiol-induced androgen receptor transactivation. The Journal of Biological Chemistry. 277: 36499-508. PMID 12068007 DOI: 10.1074/Jbc.M202824200 |
0.705 |
|
| 2002 |
Shyr CR, Collins LL, Mu XM, Platt KA, Chang C. Spermatogenesis and testis development are normal in mice lacking testicular orphan nuclear receptor 2. Molecular and Cellular Biology. 22: 4661-6. PMID 12052874 DOI: 10.1128/Mcb.22.13.4661-4666.2002 |
0.722 |
|
| 2002 |
Fu M, Wang C, Wang J, Zhang X, Sakamaki T, Yeung YG, Chang C, Hopp T, Fuqua SA, Jaffray E, Hay RT, Palvimo JJ, Jänne OA, Pestell RG. Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. Molecular and Cellular Biology. 22: 3373-88. PMID 11971970 DOI: 10.1128/Mcb.22.10.3373-3388.2002 |
0.431 |
|
| 2002 |
Heinlein CA, Chang C. Androgen receptor (AR) coregulators: an overview. Endocrine Reviews. 23: 175-200. PMID 11943742 DOI: 10.1210/Edrv.23.2.0460 |
0.446 |
|
| 2002 |
Peng WJ, Chang CM, Lin TH. Target integration by a chimeric Sp1 zinc finger domain-Moloney murine leukemia virus integrase in vivo. Journal of Biomedical Science. 9: 171-84. PMID 11914585 |
0.584 |
|
| 2002 |
Wang X, Yang Y, Guo X, Sampson ER, Hsu CL, Tsai MY, Yeh S, Wu G, Guo Y, Chang C. Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator. The Journal of Biological Chemistry. 277: 15426-31. PMID 11856738 DOI: 10.1074/Jbc.M111218200 |
0.697 |
|
| 2002 |
Shyr CR, Hu YC, Kim E, Chang C. Modulation of estrogen receptor-mediated transactivation by orphan receptor TR4 in MCF-7 cells. The Journal of Biological Chemistry. 277: 14622-8. PMID 11844790 DOI: 10.1074/Jbc.M110051200 |
0.8 |
|
| 2002 |
Ting HJ, Yeh S, Nishimura K, Chang C. Supervillin associates with androgen receptor and modulates its transcriptional activity. Proceedings of the National Academy of Sciences of the United States of America. 99: 661-6. PMID 11792840 DOI: 10.1073/Pnas.022469899 |
0.747 |
|
| 2002 |
Schinner S, Dellas C, Schroder M, Heinlein CA, Chang C, Fischer J, Knepel W. Repression of glucagon gene transcription by peroxisome proliferator-activated receptor gamma through inhibition of Pax6 transcriptional activity. The Journal of Biological Chemistry. 277: 1941-8. PMID 11707457 DOI: 10.1074/Jbc.M109718200 |
0.339 |
|
| 2002 |
Miyamoto H, Rahman M, Takatera H, Kang HY, Yeh S, Chang HC, Nishimura K, Fujimoto N, Chang C. A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth. The Journal of Biological Chemistry. 277: 4609-17. PMID 11673464 DOI: 10.1074/Jbc.M108312200 |
0.692 |
|
| 2001 |
Inui S, Nakajima T, Fukuzato Y, Fujimoto N, Chang C, Yoshikawa K, Itami S. Potential anti-androgenic activity of roxithromycin in skin. Journal of Dermatological Science. 27: 147-151. PMID 11532379 DOI: 10.1016/S0923-1811(01)00129-3 |
0.374 |
|
| 2001 |
Wang X, Yeh S, Wu G, Hsu CL, Wang L, Chiang T, Yang Y, Guo Y, Chang C. Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cells. The Journal of Biological Chemistry. 276: 40417-23. PMID 11509567 DOI: 10.1074/Jbc.M104765200 |
0.667 |
|
| 2001 |
Sampson ER, Yeh SY, Chang HC, Tsai MY, Wang X, Ting HJ, Chang C. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells. Journal of Biological Regulators and Homeostatic Agents. 15: 123-9. PMID 11501969 |
0.734 |
|
| 2001 |
Lee H, Lee Y, Chang C. TR4 orphan receptor represses the human steroid 21-hydroxylase gene expression through the monomeric AGGTCA motif. Biochemical and Biophysical Research Communications. 285: 1361-1368. PMID 11478808 DOI: 10.1006/Bbrc.2001.5342 |
0.357 |
|
| 2001 |
Lin HK, Yeh S, Kang HY, Chang C. Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Proceedings of the National Academy of Sciences of the United States of America. 98: 7200-5. PMID 11404460 DOI: 10.1073/Pnas.121173298 |
0.644 |
|
| 2001 |
Heinlein CA, Chang C. Role of chaperones in nuclear translocation and transactivation of steroid receptors. Endocrine. 14: 143-9. PMID 11394630 DOI: 10.1385/Endo:14:2:143 |
0.406 |
|
| 2001 |
Collins LL, Lin DL, Mu XM, Chang C. Feedback regulation between orphan nuclear receptor TR2 and human papilloma virus type 16. The Journal of Biological Chemistry. 276: 27316-21. PMID 11358973 DOI: 10.1074/Jbc.M104145200 |
0.32 |
|
| 2001 |
Lee DK, Duan HO, Chang C. Androgen receptor interacts with the positive elongation factor P-TEFb and enhances the efficiency of transcriptional elongation. The Journal of Biological Chemistry. 276: 9978-84. PMID 11266437 DOI: 10.1074/Jbc.M002285200 |
0.419 |
|
| 2001 |
Kang HY, Lin HK, Hu YC, Yeh S, Huang KE, Chang C. From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 98: 3018-23. PMID 11248024 DOI: 10.1073/Pnas.061305498 |
0.765 |
|
| 2001 |
Mantalaris A, Panoskaltsis N, Sakai Y, Bourne P, Chang C, Messing EM, David Wu JH. Localization of androgen receptor expression in human bone marrow Journal of Pathology. 193: 361-366. PMID 11241417 DOI: 10.1002/1096-9896(0000)9999:9999<::Aid-Path803>3.0.Co;2-W |
0.37 |
|
| 2000 |
Yeh S, Sampson ER, Lee DK, Kim E, Hsu CL, Chen YL, Chang HC, Altuwaijri S, Huang KE, Chang C. Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 99: 885-94. PMID 11155740 |
0.796 |
|
| 2000 |
Yeh S, Hu YC, Rahman M, Lin HK, Hsu CL, Ting HJ, Kang HY, Chang C. Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 97: 11256-61. PMID 11016951 DOI: 10.1073/Pnas.190353897 |
0.832 |
|
| 2000 |
Lin DL, Chang C. Identification of an essential cis-acting element (TR2-PACE) in the 5' promoter of human TR2 orphan receptor gene. Endocrine. 12: 89-97. PMID 10855696 DOI: 10.1385/Endo:12:1:89 |
0.333 |
|
| 2000 |
Wang C, Young WJ, Chang C. Isolation and characterization of the androgen receptor mutants with divergent transcriptional activity in response to hydroxyflutamide. Endocrine. 12: 69-76. PMID 10855693 DOI: 10.1385/Endo:12:1:69 |
0.42 |
|
| 2000 |
Hsiao PW, Thin TH, Lin DL, Chang C. Differential regulation of testosterone vs. 5α-dihydrotestosterone by selective androgen response elements Molecular and Cellular Biochemistry. 206: 169-175. PMID 10839207 DOI: 10.1023/A:1007024726889 |
0.396 |
|
| 2000 |
Schaick HSAv, Rosmalen JGM, Silva SLd, Chang C, Burbach JPH. Expression of the orphan receptor TR4 during brain development of the rat. Molecular Brain Research. 77: 104-110. PMID 10814836 DOI: 10.1016/S0169-328X(00)00046-2 |
0.306 |
|
| 2000 |
Mu Xm, Liu Yx, Collins LL, Kim E, Chang C. The p53/retinoblastoma-mediated repression of testicular orphan receptor-2 in the rhesus monkey with cryptorchidism. The Journal of Biological Chemistry. 275: 23877-83. PMID 10811662 DOI: 10.1074/Jbc.M910158199 |
0.313 |
|
| 2000 |
Inui S, Itami S, Pan H, Chang C. Lack of androgen receptor transcriptional activity in human keratinocytes. Journal of Dermatological Science. 23: 87-92. PMID 10808125 DOI: 10.1016/S0923-1811(99)00091-2 |
0.426 |
|
| 2000 |
Lee DK, Duan HO, Chang C. From androgen receptor to the general transcription factor TFIIH. Identification of cdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator. The Journal of Biological Chemistry. 275: 9308-13. PMID 10734072 DOI: 10.1074/Jbc.275.13.9308 |
0.469 |
|
| 2000 |
Miyamoto H, Chang C. Antiandrogens fail to block androstenedione‐mediated mutated androgen receptor transactivation in human prostate cancer cells International Journal of Urology. 7: 32-34. PMID 10701889 DOI: 10.1046/J.1442-2042.2000.00129.X |
0.425 |
|
| 2000 |
Shih CC, Young WJ, Wang CH, Jin LP, Ji XD, Guan Q, Wang M, Chang C. Monoclonal anti-androgen receptor antibodies: production, characterization and potential diagnostic applications. Molecular and Cellular Biochemistry. 201: 131-40. PMID 10630632 DOI: 10.1023/A:1007054210133 |
0.422 |
|
| 2000 |
宮本 浩, 藤本 直, 高寺 博, 上村 博, 窪田 吉, 穂坂 正, Chang C. Dominant-negative mutant of androgen receptor coactivator, ARA54, suppresses androgen receptor transactivation in prostate cancer cells The Japanese Journal of Urology. 91: 407. DOI: 10.5980/Jpnjurol.91.407_1 |
0.466 |
|
| 1999 |
Pan H, Uno H, Inui S, Fulmer NO, Chang C. Roles of testosterone in the growth of keratinocytes through bald frontal dermal papilla cells. Endocrine. 11: 321-327. PMID 10786829 DOI: 10.1385/Endo:11:3:321 |
0.317 |
|
| 1999 |
Yeh S, Kang HY, Miyamoto H, Nishimura K, Chang HC, Ting HJ, Rahman M, Lin HK, Fujimoto N, Hu YC, Mizokami A, Huang KE, Chang C. Differential induction of androgen receptor transactivation by different androgen receptor coactivators in human prostate cancer DU145 cells. Endocrine. 11: 195-202. PMID 10709768 DOI: 10.1385/Endo:11:2:195 |
0.842 |
|
| 1999 |
Lee YF, Shyr CR, Thin TH, Lin WJ, Chang C. Convergence of two repressors through heterodimer formation of androgen receptor and testicular orphan receptor-4: a unique signaling pathway in the steroid receptor superfamily. Proceedings of the National Academy of Sciences of the United States of America. 96: 14724-9. PMID 10611280 DOI: 10.1073/Pnas.96.26.14724 |
0.827 |
|
| 1999 |
Chang LY, Lin SC, Chang CS, Wong YK, Hu YC, Chang KW. Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis. Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 28: 389-96. PMID 10535361 DOI: 10.1111/J.1600-0714.1999.Tb02109.X |
0.582 |
|
| 1999 |
Chang HC, Miyamoto H, Marwah P, Lardy H, Yeh S, Huang KE, Chang C. Suppression of Δ5-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells Proceedings of the National Academy of Sciences of the United States of America. 96: 11173-11177. PMID 10500149 DOI: 10.1073/Pnas.96.20.11173 |
0.418 |
|
| 1999 |
Hsiao PW, Chang C. Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells Journal of Biological Chemistry. 274: 22373-22379. PMID 10428808 DOI: 10.1074/Jbc.274.32.22373 |
0.444 |
|
| 1999 |
Yeh S, Chang HC, Miyamoto H, Takatera H, Rahman M, Kang HY, Thin TH, Lin HK, Chang C. Differential induction of the androgen receptor transcriptional activity by selective androgen receptor coactivators. The Keio Journal of Medicine. 48: 87-92. PMID 10405524 DOI: 10.2302/Kjm.48.87 |
0.773 |
|
| 1999 |
Hsiao PW, Lin DL, Nakao R, Chang C. The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator. The Journal of Biological Chemistry. 274: 20229-34. PMID 10400640 DOI: 10.1074/Jbc.274.29.20229 |
0.35 |
|
| 1999 |
Wang C, Young WJ, Chang C. Androgen effects on the solubility and conformational change of the androgen receptor in baculovirus expression system. Molecular and Cellular Biochemistry. 195: 19-23. PMID 10395065 DOI: 10.1023/A:1006906132516 |
0.371 |
|
| 1999 |
Lee HJ, Lee YF, Chang C. Identification of the histamine H1 receptor gene as a differentially repressed target of the human TR2 orphan receptor. Molecular and Cellular Biochemistry. 194: 199-207. PMID 10391141 DOI: 10.1023/A:1006903202089 |
0.374 |
|
| 1999 |
Lee YF, Young WJ, Lin WJ, Shyr CR, Chang C. Differential regulation of direct repeat 3 vitamin D3 and direct repeat 4 thyroid hormone signaling pathways by the human TR4 orphan receptor. The Journal of Biological Chemistry. 274: 16198-205. PMID 10347174 DOI: 10.1074/Jbc.274.23.16198 |
0.793 |
|
| 1999 |
Heinlein CA, Ting HJ, Yeh S, Chang C. Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma. The Journal of Biological Chemistry. 274: 16147-52. PMID 10347167 DOI: 10.1074/Jbc.274.23.16147 |
0.718 |
|
| 1999 |
Yeh S, Lin HK, Kang HY, Thin TH, Lin MF, Chang C. From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 96: 5458-63. PMID 10318905 DOI: 10.1073/Pnas.96.10.5458 |
0.661 |
|
| 1999 |
Inui S, Lee Y, Haake AR, Goldsmith LA, Chang C. Induction of TR4 Orphan Receptor by Retinoic Acid in Human HaCaT Keratinocytes Journal of Investigative Dermatology. 112: 426-431. PMID 10201524 DOI: 10.1046/J.1523-1747.1999.00548.X |
0.339 |
|
| 1999 |
Kang H, Yeh S, Fujimoto N, Chang C. Cloning and Characterization of Human Prostate Coactivator ARA54, a Novel Protein That Associates with the Androgen Receptor Journal of Biological Chemistry. 274: 8570-8576. PMID 10085091 DOI: 10.1074/Jbc.274.13.8570 |
0.488 |
|
| 1999 |
Fujimoto N, Yeh S, Kang HY, Inui S, Chang HC, Mizokami A, Chang C. Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate. The Journal of Biological Chemistry. 274: 8316-21. PMID 10075738 DOI: 10.1074/Jbc.274.12.8316 |
0.478 |
|
| Show low-probability matches. |